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INVESTIGATION OF ISCHEMIA-REPERFUSION EFFECTS ON DUSP1 
AND CXCL2 GENE EXPRESSION IN RAT KIDNEY TISSUES USING      
RT-PCR AND REAL-TIME PCR  
 
SUMMARY 
 
Ischemia is a restriction in blood supply, due to factors in the blood vessel with 
damage or dysfunction of tissue. Cellular metabolism prefers anaerobic pathways 
due to insufficient oxygen. Reperfusion injury refers to damage to tissue caused 
when blood supply returns to the tissue after a period of ischemia. Restoration of 
blood flow triggers the production of Reactive oxygen species (ROS) which can 
initiate a wide range of toxic oxidative reactions. ROS can react directly with cellular 
lipids, proteins and DNA leading to cell injury/death. Inflammation plays an 
important role in ischemia reperfusion injury. 
In recent studies, ischemic preconditioning and heat preconditioning have been used 
as a therapy. Ischemic preconditioning (IP) is describing a condition that prior 
ischemic stress renders the organ resistant to a subsequent ischemic insult. Heat 
preconditioning was the first stress shown to induce the synthesis of heat shock 
proteins (Hsps) and has an anti-inflammatory, antiapoptotic effect. The described 
forms of preconditioning provide protective effect on kidney.  
Dual specificity of phosphatases (DUSPs) inactivate MAPKs which are important 
players in signal transduction pathways activated by a range of stimuli and mediate a 
number of physiological and pathological changes in cell function via 
dephosphorylation of these phosphothreonine and phosphotyrosine residues. CXCL2 
which is a chemokine that is in CXC family plays a crucial role in neutrophil 
recruitment in the post-ischemic kidney mediating tissue injury via cytokines, free 
radical intermediates, and proteases. In a previous study with microarray analysis, it 
was observed that DUSP1 and CXCL2 genes were upregulated when rat kidney 
tissues were studied for gene expression upon ischemia-reperfusion, ischemia-
reperfusion with heat preconditioning and with ischemic preconditioning. 
The aim of this study was to investigate the effects of ischemia reperfusion, IP, HP 
on DUSP1 and CXCL2 gene expression in rat kidney tissues using reverse 
transcriptase PCR and real-time q-PCR methods and compare the results with 
previous microarray data.  
The results showed that  DUSP1 gene expression was highest when reperfusion time 
was 60 min and also highest in IP group among all conditions tested. IP generally 
increases CXCL2 gene expression. However, in HP and IRI groups, CXCL2 gene 
expression increases as a function of reperfusion time. Real-time PCR results were in 
good agreement with the previously obtained microarray results. The ranges of 
relative quantification values were higher in real-time PCR results. Friedman test 
proved that the result of the three experimental methods were not significantly 
different from each other.  
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The early preconditioning effects on DUSP1 and CXCL2 gene expression levels 
were investigated in this study. New experiments could be designed to investigate 
late preconditioning effects by extending reperfusion time beyond 60 min. 
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RT-PCR VE GERÇEK ZAMANLI PCR KULLANILARAK SIÇAN BÖBREK 
DOKULARINDA DUSP1 VE CXCL2 GENLERİ ÜZERİNDEKİ İSKEMİ 
REPERFÜZYON ETKİLERİNİN İNCELENMESİ  
ÖZET 
İskemi damarlardaki hasara veya dokulardaki işlev bozukluğuna bağlı olarak kan 
akışındaki kısıtlamadır. Hücre metabolizması kısıtlı oksijen varlığında anaerobik 
yolizlerini tercih eder. Reperfüzyon ise belli bir süre iskemiden sonra dokulara kan 
akışının tekrar sağlanması sonucu dokuya verilen hasardır. Kan akışının geri 
kazanımı geniş bir alanda toksik oksidatif reaksiyon başlatabilen reaktif oksijen 
türlerinin oluşumunu tetiklemektedir. Reaktif oksijen türleri hücre lipidleri, protein 
ve DNA ile direkt reaksiyona girerek hücre hasarı ve/veya hücre ölümüne sebep 
olmaktadır. Enflamasyon iskemi repefüzyon hasarında önemli rol oynamaktadır.  
Son senelerde yapılan çalışmalarda, iskemi önkoşullaması ve ısı önkoşullaması terapi 
olarak kullanılmaktadır. Isı önkoşullaması önceki iskemi stresin sonra oluşacak 
iskemiye karşı daha dirençli olmasını sağlayan bir olgudur. Isı önkoşullaması ısı 
şoku proteinlerinin indüklendiğini gösteren ilk strestir ve antiinflamatuar ve hücre 
ölümünü engelleyen özelliklere sahiptir. Bu önkoşullamalar böbreğe koruyucu etki 
sağlamaktadır. 
DUSPs sinyal iletim yolizinde çeşitli uyarıcılar tarafından aktive olan MAPKleri 
inaktive ederek hücre fonksitonlarındaki fizyolojik ve patalojik değişimleri kontrol 
etmektedir. CXCL2 iskemi sonrası böbrekte sitokin, serbest radikal aracıları ve 
proteazları sayesinde oluşan doku hasarında nötrofil toplanmasında çok önemli rol 
oynamaktadır. 
Mikroarray analizi yapılan daha önceki bir çalışmada, sıçan böbrek dokularında 
iskemi-reperfüzyon, ısı önkoşullamalı iskemi reperfüzyon ve iskemi önkoşullamalı 
iskemi reperfüzyon üzerinde gen ekspresyonu çalışıldığı zaman DUSP1 ve CXCL2 
gen anlatımının arttığı gözlenmiştir. 
Bu çalışmanın amacı revers transkriptaz Polimeraz Zincir Reaksyonu ve Gerçek-
Zamanlı Polimeraz Zincir Reaksiyonu metotlarını kullanarak sıçan böbrek 
dokularında iskemi reperfüzyon, iskemi önkoşullaması ve ısı önkoşullamasının 
DUSP1 ve CXCL2 gen ekspresyonu üzerindeki etkilerinin araştırılması ve bu 
sonuçların önceki mikroarray verileri ile karşılaştırılmasıdır.  
Sonuçlar, DUSP1 gen ekspresyonunun reperfüzyon süresi 60 dakika olduğunda en 
yüksek olduğunu ve test edilen tüm koşullar arasında en yüksek ekspresyonun iskemi 
önkoşullaması grubunda olduğunu göstermiştir. İskemi önkoşullaması CXCL2 
geninin ekspresyonunu arttırmaktadır. Fakat ısı önkoşullaması ve IRI gruplarında 
CXCL2 geninin ekspresyonu reperfüzyon süresine bağlı olarak artış göstermektedir. 
Real-time PCR sonuçları, önceki mikroarray sonuçları ile uyumludur. Göreceli 
ölçüm değerleri, gerçek zamanlı PCR sonuçlarında diğer metotlara kıyasla daha 
yüksektir. Friedman testi, her üç deneysel metot sonuçlarının birbirinden ciddi 
ölçüde farklı olmadığını kanıtlamıştır.  
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Bu çalışmada, erken iskemi önkoşullamasının DUSP1 ve CXCL2 genlerinin 
ekspresyonu üzerine etkisi araştırılmıştır. Geç iskemi önkoşullama etkisinin 
araştırılması için reperfüzyon süresi 60 dakika üzerine çıkarılarak yeni deneyler 
tasarlanabilir.
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1.  INTRODUCTION  
1.1 Ischemia Reperfusion Injury 
Ischemia/reperfusion injury (IRI) is a complex phenomenon and an unavoidable 
consequence of organ transplantation that occurs during a number of stages in the 
transplantation procedure. IRI may begin in the donor as a result of brain death, 
continue during the process of organ procurement and cold ischemic storage and 
further it will continue during warm ischemia. It is not only an invariable 
consequence of transplantation but also results from circumstances such as cross 
clamping and resuscitation following systemic hypotension (Koo and Fuggle, 2000; 
De Groot and Rauen, 2007; Weight et al., 1996). It is associated with increased 
morbidity, prolonged hospitilizations and increased mortality (Thurman, 2007). 
1.1.1 Ischemia 
Ischemia is a restriction in blood supply, due to factors in the blood vessel with 
damage or dysfunction of tissue. Insufficient oxygen intake and conversion of 
cellular metabolism to anaerobic pathways are the characteristics of ischemia 
(Siemionow and Arslan, 2004). Ischemic tissue is depleted of oxygen and nutrients 
(Koo and Fuggle, 2000). Anoxic injury of O2-dependent cells in ischemia is clearly 
the predominant injury process (De Groot and Rauen, 2007). Long periods of 
ischemia can alter the electron transport complexes in mitochondria (Siemionow and 
Arslan, 2004).  
Mitochondrial energy production decreases and ATP content also decreases. ATP is 
dephosphorylated to adenosine diphosphate, adenosine monophosphate, and purines 
(Koo and Fuggle, 2000; De Groot and Rauen, 2007). In the kidney, 95% of ATP is 
lost within 4 hours of ischemia (Koo and Fuggle, 2000). 
Dysregulation of cellular ion homeostasis resulting in ischemia-induced acidosis and 
increase in intracellular calcium concentration is a crucial feature of ischemia 
(Siemionow and Arslan, 2004; Dorweiler et al., 2007).  
The sodium-(Na+)-potassium (K+)-ATPase, that  removes sodium from the cytosol, 
is inhibited during ischemia-induced ATP-depletion so that the sodium (Na+)-
  
2 
calcium (Ca++)-exchanger moves sodium out of the cell. Extracellular calcium is 
consequently transported into the cytosol and results in intracellular calcium 
overload (Dorweiler et al., 2007). Acting as a second messenger, calcium triggers the 
activation of several enzymes such as  phospholipases (especially phospholipase A2) 
and proteases (calpains and others) and proinflammatory mediators accumulate 
(Siemionow and Arslan, 2004; Bohmova and Vicklicky, 2001). Cellular influx of 
water and swelling occurred as a consequence of an intracellular accumulation of 
sodium and calcium ions (Bohmova and Vicklicky, 2001).   
Under physiological conditions, hypoxanthine is converted to xanthine by the 
enzyme xanthine dehydrogenase with consumption of nicotinamide adenine 
dinucleotide (NAD). However, in  ischemia phase, xanthine dehydrogenase (D-form) 
undergoes a conformational change to xanthine oxidase (O-form) by intracellular 
Ca
++ 
increase, and xanthine oxidase can generate reactive oxygen species (ROS) 
(Dorweiler et al., 2007). Akçetin et al.(1999) demonstrated that xanthine oxidase was 
the main oxygen radical generator in the very early reperfusion period after ischemia. 
The duration of ischemia determines the severity of tissue damage (Siemionow and 
Arslan, 2004). 
1.1.2 Reperfusion 
Reperfusion injury refers to damage to tissue caused when blood supply returns to 
the tissue after a period of ischemia. Restoration of blood flow initiates a cascade of 
events that may lead to additional cell injury, beyond that caused by the ischemia 
(Siemionow and Arslan, 2004).  The return of oxygenated blood on reperfusion may 
lead to a chain of damaging events that results in the production of reactive oxygen 
species (ROS) an endothelial cell damage. Reactive oxygen and nitrogen species are 
important mediators and modulators of postischemic tissue injury in a number of 
different organ systems including kidney (Abe et al., 2009).  
Reactive oxygen species can initiate a wide range of toxic oxidative reactions. These 
reactions are  the initiation of  lipid peroxidation, direct inhibition of mitochondrial 
respiratory chain enzymes, inactivation of glyceraldehyde-3 phosphate 
dehydrogenase,  inhibition of membrane sodium-potassium ATPase activity, 
inactivation of membrane sodium channels, and other oxidative modifications of 
proteins (Cuzzocrea and Reiter, 2001). 
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ROS can react directly with cellular lipids, proteins and DNA leading to cell 
injury/death and activation of  NF-kB (Dorweiler et al., 2007). 
 
 
Figure 1.1: Free radicals and reactive oxygen intermediates (Cuzzocrea and Reiter,   
2001) 
O2 is enzymatically reduced to hydrogen peroxide (H2O2) in the presence of  a 
ubiquitously distributed enzyme, superoxide dismutase (SOD) which can be  
classified as an antioxidative enzyme that affords protection against free radical 
damage. In some cases, it can also be associated with increased oxidative stress  
(Cuzzocrea and Reiter, 2001). H2O2 does not possess an unpaired electron  and  is 
not a free radical. It is usually classified as a reactive oxygen intermediate or species. 
It can diffuse though membranes and it has a half-life much longer than that of O2. 
But in the presence of the transition metals Fe
+2
 or Cu
+1
, it is reduced to OH
- 
. OH
-
 is 
extremely reactive and highly toxic. It indiscriminately reacts with any molecule it 
encounters. It is classified as the radical‘s radical. Because of its large size and 
electroreactivity, it is not uncommon for OH
-
 to interact and produce damage to 
macromolecules such as DNA, proteins, carbohydrates, and lipids. Oxidative damage 
to macromolecules is especially noticeable because compared to the smaller 
molecules in cells, they are present in limited numbers (Figure 1.1) (Cuzzocrea and 
Reiter, 2001). In the kidney, ROS are produced in significant amounts in renal 
proximal tubules rather than distal tubular epithelium under ischemia reperfusion 
(Chiang-Ting et al., 2005). 
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Inflammation plays an important role with involvement of leukocytes, adhesion 
molecules, endothelial activation and dysfunction, adherence and activation of 
neutrophils and platelets  and the activation of complement  and T cells chemokines 
and cytokines (Huang et al., 2007; Foley and Chari, 2007). The accumulation of 
reactive oxygen species (ROS)  initiate tissue injury and stimulate a cellular cascade 
leading to inflammation. The proinflammatory process that follows results in cell 
death and in severe cases leads ultimately to organ failure ( Foley and Chari, 2007). 
 
Figure 1.2:  Overview of early immune response occurring in post-ischemic kidneys 
(Jang and Rabb, 2008) 
In experimental ischemia reperfusion-induced acute kidney injury models, after  
ischemic insult occurs, reperfusion initiates inflammation in post-ischemic kidneys 
with entry of blood containing major cellular components of innate immunity, plus 
lymphocytes. Leukocytes including neutrophils, macrophages and lymphocytes 
gather in post-ischemic kidneys. Cytokines and complement system also cause renal 
injury. Early injury events are observed at the level of the microvasculature first and 
then in the tubular interstitial space. Leukocytes and platelets plug renal 
microcirculation and each immune component cause robust inflammatory responses 
in the tubular interstitial space (Figure 1.2) (Jang and Rabb, 2008). 
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NO is recognized as an important mediator of physiological and pathological 
processes of renal I/R injury (Chen et al., 2007). The endothelial barrier between the 
circulation and surrounding tissues secretes vasoconstrictors (eg, endothelin) and 
vasodilatory molecules (eg, nitric oxide [NO]) to regulate blood pressure and flow. 
NO is expressed constitutively at basal levels on the endothelial surface by the 
calcium-/calmodulin-dependent enzyme, NO synthase (eNOS), and an inducible 
isoform (iNOS). eNOS is expressed in the renal vasculature and tubular epithelium, 
whereas iNOS may be expressed by the proximal tubules, glomeruli, and inner 
medullary collecting ducts (Koo and Fuggle, 2000). The role of NO in I/R is still 
controversial. NO can induce cellular cytotoxicity and tissue injury via lipid 
peroxidation, DNA damage, and pro-apoptotic effects, which are included in I/R 
injury (Chen et al., 2007). On the other hand, many studies have demonstrated that 
the increased activity of NOS was associated with reduced I/R-induced injury by 
acting  in a tissue-protective manner through the physiological regulation of vascular 
tone, inhibition of platelet aggregation, attenuation of leukocyte adherence to the 
endothelium, scavenging of oxygen-derived free radicals, maintenance of normal 
vascular permeability, inhibition of smooth muscle proliferation, immune defense, 
and stimulation of endothelial cell regeneration (Chen et al., 2007; Siemionow and 
Arslan, 2004). 
Cell death occurs both via necrosis and apoptosis in ischemia reperfusion injury. 
During the degenerative process of necrosis, cellular integrity is lost and the release 
of cytosolic contents elicits an inflammatory response whereby the extent of necrotic 
cell loss is a function of the duration of ischemia (Dorweiler et al., 2007). Apoptosis 
can be defined as the morphologically defined form of programmed cell death. This 
differs from tissue necrosis, which is another major form of cell death (Siemionow 
and Arslan, 2004). 
Apoptosis is a highly regulated, energy (ATP) dependent mechanism that leads to 
cellular degradation into membrane-covered apoptotic bodies that are removed by 
macrophages without provoking an inflammatory response. Ischemia itself triggers 
apoptosis whereas reperfusion accelerates the process and may lead to an 
enhancement of apoptosis as reperfusion restores the energy required for the 
completion of apoptosis (Dorweiler et al., 2007).  
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Cell-cell interactions are possible mechanisms underlying the development of 
apoptosis during reperfusion. Interactions between blood cells and vascular 
endothelial cells and the release of cytokines and generation of reactive oxygen 
species from activated neutrophils, endothelial cells, and myocytes during 
reperfusion were triggers for the induction of apoptosis. These interactions are 
initiated within the early moments of reperfusion, and may continue during the 
following hours and days (Siemionow and Arslan, 2004). 
The pathway of necrosis and apoptosis in  ischemia-reperfusion is activation of 
intrinsic and death receptor-dependent (extrinsic) pathways assemble to 
mitochondria to induce membrane permeabilization. Bax/Bak dependent 
permeabilization of the outer membrane is caused by BH3 only Bcl-2 family 
members, including tBid formed by death receptor-linked caspase 8 activation.  
Formation of channels in the outer membrane or induction of mitochondrial 
permeability transition (MPT) followed by mitochondrial swelling and outer 
membrane rupture may be triggered by permeabilization. After membrane 
permeabilization, cytochrome c is released to the cytosol and first activates caspase 9 
and then caspase 3 in a reaction requiring ATP. If MPT onset is sudden and involves 
most mitochondria, ATP becomes profoundly depleted and depletion of ATP blocks 
caspase activation. Instead, plasma membrane rupture and the onset of necrotic cell 
death are culminated by ATP depletion (Casillas-Ramirez et al., 2006). 
1.2 Preconditioning 
1.2.1 Ischemic preconditioning 
Ischemic preconditioning (IPC) is the phenomenon that a prior ischemic stress 
renders the organ resistant to a subsequent ischemic insult (Liu et al., 2007). The 
phenomenon of IPC was described in 1986 by Murry et al. using a canine heart 
ischemia model. 
In that study, a group of open-chest dogs were exposed  to a four cyclic episode of 5-
min coronary occlusions followed by 5 min reperfusion and then subjected to a 
prolonged ischemic insult (40 min coronary occlusion followed by 4 days of 
reperfusion). Control dogs received only 40-min coronary occlusion. Those group of 
dogs that received four cyclic episodes of 5 min occlusion, followed by 5 min 
reperfusion before prolonged ischemia, had much smaller myocardial infarct size 
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compared with control group, although that group received additional 20 min 
ischemia. The term ‗‗ischemic PC‘‘ was introduced  to describe this phenomenon 
(Murry et al., 1986). 
After this first discovery in 1986, it was found that ischemic preconditioning had two 
phases called early preconditioning (lasts for 2–3 h) and (ii) late preconditioning 
(starting at 24 h lasting until 72–96 h after initial ischemia) (Bolli, 2000). 
Early preconditioning depends on adenosine, opioids and to a lesser degree, on 
bradykinin and prostaglandins, released during ischemia. These molecules activate 
G-protein-coupled receptor, initiate activation of  KATP channel and generate 
oxygen free radicals, and stimulate a series of protein kinases, which include protein 
kinase C, tyrosine kinase, and members of MAP kinase family. Late preconditioning 
is triggered by a similar sequence of events, but in addition essentially depends on 
newly synthesized proteins, which comprise iNOS, COX-2, manganese superoxide 
dismutase, and possibly heat shock proteins (Figure 1.3) (Das and Das., 2008). 
 
Figure 1.3: Schematic representation of the cellular mechanisms underlying late PC 
(Bolli, 2000). 
One of the earlier genes identified as the mediator of late PC was the inducible 
isoform of NOS (iNOS); subsequently, other genes have been identified, including 
cyclooxygenase-2 (COX- 2), heme oxygenase-1 (HO-1), antioxidant enzymes such 
as extracellular SOD (ecSOD) and aldose reductase. Briefly, the possible mechanism 
by which NO enhances the resistance of myocardium to ischemia reperfusion injury 
include inhibition of calcium influx, reduction of myocardial oxygen demands, and 
opening of mitochondrial KATP channel.  It was found that after a standard ischemic 
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PC protocol, there was robust upregulation of COX-2 protein and increase in the 
levels of COX-2 byproduct, prostanoids (PGI2 and PGE2), well known for their 
cardioprotective action (Das and Das, 2008). 
The most widespread method used in experimental procedure of preconditioning is 
using four-cycle preconditioning schedule. This procedure may be confusing and 
complex and results have not always been conclusive in the organs especially in the 
kidney (Torras et al., 2002) 
The beneficial effects of using multiple cycles over single cycle IPC, that is, cycles 
of multiple brief IPC, is correlative to its protective effect and is poorly understood 
(Li et al., 2005). Li et al found that IPC with 3 cycles is more protective compared to 
single or 2 cycles of IPC in dog kidney. Torras et al indicate that the protective effect 
of renal ischemic preconditioning is related to the local production of NO and found 
that 15 min of warm ischemia and 10 min of reperfusion in the kidney was the most 
suitable one-cycle schedule for preconditioning since it protected from both warm 
and cold ischemia. 
Some of  agents that simulate ischemic preconditioning without inducing ischemia 
have been studied in humans and adenosine, adenosine agonists, nicorandil, volatile 
anaesthetics, and nitroglycerin are used for pharmacological ischemia 
preconditioning (Casillas-Ramirez et al., 2006). 
The use of IPC in clinical solid organ transplantation has its limitations. Inducing a 
period of ischemia before cold preservation to the donor organ has the potential to 
cause vascular injury or worsen posttransplant function. In addition, it cannot be used 
in the recovery of organs from DCD donors observing that the patient sustains 
cardiopulmonary arrest before organ procurement. No clinical trials have been 
published to date that examine the role of IPC in human kidney transplantation 
(Foley and Chari, 2007). 
1.2.2 Heat preconditioning 
It was the first stress shown to induce the synthesis of heat stress proteins (Hsps), in 
particular the inducible form Hsp70, in the heart and other tissues. Currie et al. 
(1988) were the first to show that 24 h after heat stress (HS), isolated rat hearts 
exhibited improved contractile recovery upon reperfusion compared to control 
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hearts. Since then, this observation has been extended to the rabbit and the dog 
(Joyeux-Faure et al., 2003). 
The components of the mechanism of the heat preconditioning are i) Triggers of HS 
preconditioning which helps the generation of a wide variety of metabolites and 
ligands to trigger the development of protection, ii) Signalling aspects of HS 
preconditioning which trigger HS preconditioning by activating a complex cascade 
of signalling events that ultimately result in increased transcription of 
cardioprotective genes , iii) Mediators of HS preconditioning. 
Triggers of heat preconditioning are: catecholamines, nitric oxide, reactive oxygen 
species, cytokines, heme oxygenase-1 pathway, opioids. Signalling pathways that are 
signaling aspects of HS preconditioning are phospholipase C and protein kinase C, 
protein tyrosine kinases, and mitogen-activated protein kinases. At the end the 
meditators that increase the effect of protection are heat stress proteins, nitric oxide, 
cyclooxygenase-2, endogenous cannabinoids, KATP channels, antioxidant enzymes 
and calcium homeostasis (Figure 1.4) (Joyeux-Faure et al., 2003). 
 
 
Figure 1.4: Hypothetical representation of cellular events thought to occur following 
heat stress preconditioning (Joyeux-Faure et al., 2003). 
Heat preconditioning is known to be protective in various types of injury. Heat shock 
has an anti-inflammatory, antiapoptotic effect. Heat preconditioning provided 
marked functional protection and also reduced histological evidence of tubular 
necrosis. It had effects on ischemic acute renal failure (ARF). It suppressed 
ischemia/reperfusion induced NF-kB activation and decreased tubular cell apoptosis 
and caspase 3 activation. HSP-70 was induced only among several heat shock 
proteins (HSP)  by heat preconditioning (Jo et al., 2006). 
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HSP-70 has been demonstrated to be protective in renal tubular cell apoptosis that is 
induced by inflammatory cytokine or ATP depletion (Jo et al., 2006 ). 
HSP70 was induced by heat preconditioning and it protected renal tubular epithelia 
cells from Ca
+2
 mediated injury which was induced by ischemic damage (Kuhlmann 
et al., 1997). 
The two genes - HSP70-1 gene and HSP70-2 gene -that regulates HSP70i were 
induced after ischemia. HSP70-2 is more sensitive to injury, thus it is activated 
immediately. However, HSP70-1 gene controls heat shock protein induction after 
severe injury (Akçetin et al., 1999).  
Heat-shock preconditioning protects liver from microcirculatory failure which 
occured after ischemia/reperfusion (I/R) by inducing expression of heat shock 
protein 72 (HSP72) and heme oxygenase (HO-1) (Yamagami et al., 2003). 
1.3 DUSP1 Gene 
Innate immune cells such as macrophages and dendritic cells localized in the affected 
tissues detect the pathogen-associated molecular patterns through their specialized 
receptors including Toll-like receptors (TLR) (Wang and Liu, 2007). Engagement of 
Toll-like receptors (TLRs) on macrophages leads to activation of the mitogen-
activated protein kinases (MAPKs), which contribute to innate immune responses 
(Chi et al., 2005). NF-κB  is also upregulated to bind to the promoter regions of 
many pro-inflammatory cytokine and chemokine genes and activate their 
transcription (Wang and Liu, 2007 ). Mitogen-activated protein (MAP) kinases are 
important players in signal transduction pathways activated by a range of stimuli and 
mediate a number of physiological and pathological changes in cell function (Camps 
et al., 2000). 
MAPKs are activated by phosphorylation on both the threonine and tyrosine residues 
of a conserved signature T-X-Y motif within the activation loop of the kinase 
(Keyse, 2008). 
The reversible nature of MAPK phosphorylation suggests that the phosphatases play 
a key role in regulating MAPK acitivity. A growing family of dual specificity of 
phosphatases have been identified that inactivate MAPKs via dephosphorylation of 
these phosphothreonine and phosphotyrosine residues (Franklin et al.,1998). MKP 
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include serine-threonine phosphatases (PP2A and PP2C), the tyrosine phosphatases 
PTPN5, PTPN7, and PTPRR , and members of the DUSP family. Of the 30 protein-
coding DUSP genes found in the human genome, 11 are bona fide MKP because in 
addition to the DUSP domain they contain a MAPK binding domain (MKB). The 19 
atypical DUSP are much smaller proteins that lack such aMKB, but may still 
function as MKP (Lang et al., 2006). In 1992, the first mammalian DUSP was 
identified as the mouse immediate early gene 3CH134 (later also cloned as Erp) or 
its human orthologue CL100, or its rat ortolog DUSP1 which is induced rapidly after 
exposure to growth factors, heat shock, or oxidative stress (Camps et al., 2000).  
The three major subfamilies of MAPK that are expressed in the immune system are 
p38, ERK, and JNK (Lang et al., 2006). 
MKP-1 localizes to the nucleus through its N terminus and preferentially 
dephosphorylates activated p38 MAPK and c-Jun N-terminal kinase (JNK) relative 
to extracellular signal regulated kinase (ERK) in vitro (Table 1.1) (Chi et al., 2005). 
Table 1.1 : General features of mammalian DUSPs (Camps et al., 2000) 
Human 
gene 
Species 
orthologue 
Tissue  
distribution 
Subcellular 
localization 
Transcriptional 
induction 
Chromosomal 
localization 
MAPK  
specificity 
hVH1/ 
CL100 
MKP1/ 
3CH134/ 
Erp (mouse) 
Heart 
Skelatal muscle 
Pancreas 
Placenta 
liver 
Testes 
Stomach 
Brain lung 
Nuclear Mitogens 
Growth factors 
Oxidative 
stress 
Heat shock 
Brain ischemia 
Brain seixure 
activity 
5q35 p38> 
JNK/SAPK>  
ERK 
 
Although group of phosphatases exhibit differential substrate specificities toward 
different MAP kinases, many of the phosphatases also share substrates. For example, 
MKP-1 has been shown to prefer p38 and JNK as substrates, although it was 
originally characterized as an ERK phosphatase. In macrophages, at least four MKPs 
are expressed: MKP-1, MKP-2, phosphatase of activated cells 1, and MKP-5/MKP-
M. It is possible that multiple MKPs act cooperatively to control the MAP kinase 
cascades. In the absence of MKP-1 protein, JNK and p38 will be eventually 
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inactivated by other MKPs, albeit at a much slower rate (Figure 1.5) (Zhao et al., 
2005). 
 
Figure 1.5: Feedback control of MAP kinases by MKP-1 (Wang and Liu, 2007)  
Since the initial cloning of CL100/MKP-1, eight additional mammalian DSP gene 
family members have been identified and characterized. Another interesting feature 
of  DUSPs is their tight and rapid transcriptional induction by growth factors and/or 
cellular stresses. Indeed, CL100/MKP-1 was identified originally as an immediate 
early gene induced rapidly within 30–120 min in cultured cells by mitogens, heat 
shock, or oxidative stress (Camps et al., 2000). MKP-1 regulates both 
proinflammatory and anti-inflammatory cytokines in LPS-stimulated macrophages 
(Chi et al., 2005). 
DUSP1/MKP-1 gene is a transcriptional target of the p53 tumour suppressor and is 
also up-regulated in response to a variety of cellular stress conditions including 
oxidative stress and DNA-damaging agents. Interestingly, DUSP1/MKP-1 is also up-
regulated in response to hypoxia at levels found in solid tumours, suggesting that it 
may play a key role in the regulation of MAPK activities within the tumour 
microenvironment (Keyse, 2008). 
Liu et al. (2005) mentioned that hypoxia induces  MKP-1 expression and hypoxia 
induced MKP-1 protects overactivation of HIF-1 activation through inhibiting ERK 
kinase acitivity. 
Seo et al. (2006) mentioned about interaction between HSP25 or HSP70i and MKP1 
dephosphorylated ERK1/2. Interaction of MKP1 with HSP25 or HSP70i activates 
MKP1 phosphorylation and then ERK1/2 inactivation, resulting in HSF1 
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dephosphorylation on serine 307. It shows that DUSP1 gene has interaction with heat 
shock proteins. It is known that the promoter sequence of the MKP-1 gene contains 
AP-1 and CRE sites, which respond to protein kinase C and Ca
2+
/cAMP signaling 
pathways. Indeed, stimuli which activate protein kinase C, increase the intracellular 
cAMP content or raise the concentrations of Ca
2+
, also increase the expression of 
mRNA for MKP-1 (Engelbrecht et al., 2005). Thus, upregulation during ischemia is 
possible.  
It is demonstrated that MKP-1 is a critical negative regulator in the innate immune 
response to LPS. It is found that MKP-1 is induced by LPS and plays a critical role 
in the attenuation of both JNK and p38 in peritoneal macrophages (Zhao et al., 
2005). 
MKP-1 provide cytoprotection against UV-induced apoptosis. However, this was not 
observed with other DUSPs. Thus, this finding demonstrates that the survival 
advantage provided by MKP-1 is not a universal feature of all dual specificity 
phosphatases (Franklin et al., 1998). 
1.4 CXCL2 Gene 
The biological purpose of  inflammation is to bring fluids, proteins and inflammatory 
cells such as neutrophils and monocytes from the blood into the damaged tissues to 
eliminate the injuring agents and trigger the healing and repairing processes. 
Development of inflammatory reactions is controlled by a number of cellular and 
molecular components, including proinflammatory cytokines (Yamamoto et al., 
2008). 
The mammalian immune system has two major components called the innate 
immunity and the adaptive immunity. The innate immune system serves as a first 
line of defense against pathogenic organisms. The innate immune system is 
comprised of a number of cell types, including dendritic cells, macrophages and 
monocytes, polymorphonuclear cells, natural killer cells, γδ T cells, and natural killer 
T cells. The adaptive immunity is a pathogen-specific host defense based on B- and 
T-lymphocytes (Wang and Liu, 2007). Major function of the innate immune cell  is 
the production of inflammatory mediators such as cytokines and chemokines. 
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Cytokines are low-molecular-weight (approximately 25 kDa) regulatory proteins or 
glycoproteins released from various cells, mainly from leukocytes, usually by 
various activating stimuli, and regulate the development and effector functions of 
immune cells. Cytokines clearly play an important role in both local and distant 
organ effects of acute kidney injury (Jang and Rabb., 2008). Chemokines are 
cytokines with chemoattractant properties for leukocytes. Cells respond to 
chemokines by their expression of specific membrane-spanning G-protein coupled 
receptors (Tarzami et al., 2001). Chemokines have three subtypes according to the 
number of amino acids between the first two cysteines; CC, CXC and CX3C families 
(Jang and Rabb, 2008). CC chemokines are the most numerous and diverse family, 
including at least 25 ligands in humans. CXC chemokines are further classified 
according to the presence of the tripeptide motif glutamic acid-leucine-arginine 
(ELR) in the NH2 terminal region (Frangogiannis, 2004). 
Chemokines can be divided broadly into two categories: homeostatic chemokines are 
constitutively expressed in certain tissues and may be responsible for basal leukocyte 
trafficking and formation of the fundamental architecture of lymphoid organs, and 
inducible chemokines which are strongly upregulated by inflammatory or immune 
stimuli, actively participating in the inflammatory reactions by inducing leukocyte 
recruitment (Frangogiannis, 2004). 
Cytokines and chemokines are essential for the mobilization of the leukocytes to the 
site of infection, the initiation of the adaptive immune response, and the initiation of 
acute phase response; the reactive nitrogen and oxygen species are crucial for the 
killing of the invading pathogens (Wang and Liu, 2007). 
Mononuclear cells play a key role in the synthesis of proinflammatory cytokines. 
These proinflammatory cytokines can in turn trigger secondary inflammatory 
cascades, including the production of cytokines, lipid mediators, and reactive oxygen 
species, as well as the up-regulation of cell adhesion molecules that facilitate the 
migration of inflammatory cells into tissues. By inducing the expression of inducible 
nitric oxide synthase and augmenting the production of nitric oxide, proinflammatory 
cytokines can decrease systemic vascular resistance, resulting in profound 
hypotension. Moreover, these cytokines also stimulate the procoagulation pathway, 
leading to thrombosis of microvasculature and impaired tissue perfusion. The 
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combination of hypotension and microvascular occlusion results in tissue ischemia 
and ultimately leads to multiple organ failure (Zhao et al., 2005). 
Among four subfamilies of chemokines, CXC chemokines such as CXCL8 and its 
functional homolog CXCL2 are known to show potent neutrophil chemotactic 
activity (Sonoda  et al., 1998). 
At inflamed sites, neutrophils deploy a potent antimicrobial arsenal that includes 
proteinases, antimicrobial peptides and ROS. Although ROS are extremely 
antimicrobial by virtue of their ability to kill microbial pathogens, in chronic 
inflammation, the continued production of ROS by neutrophils causes extensive 
tissue damage. Traditionally, this has been considered as random damage to cellular 
components (Yamamoto et al., 2008). 
Recently, ROS have emerged as signal transduction molecules. In inflammatory 
cells, ROS contribute to the expression of a variety of different inflammatory 
cytokines, adhesion molecules and enzymes by activating redox-sensitive 
transcription factors such as nuclear factor-kB (NF-kB) (Droge, 2002). 
Once monocytes adhere to endothelial cells from the bloodstream and migrate 
toward tissues, they differentiate into macrophages. During homeostasis, monocytes 
and macrophages phagocytose and remove senescent and apoptotic cells, whereas 
during inflammation they are the main effectors of innate immunity because of their 
antimicrobial activity and production of proinflammatory cytokines (Yamamoto et 
al., 2008). In human monocytes, CXCL8 production is induced by ROS, including by 
H2O2 (Josse et al., 2001) via Erk-activated NF-kB (Zeng et al., 2003). 
CXC chemokines are also up-regulated in remote organs, including lung, and play an 
important role in the development of remote organ injury after liver 
ischemia/reperfusion (Lentsch et al., 2000) 
Chemokine induction during the inflammatory response after ischemia reperfusion 
injury has been reported in several organs such as brain, heart, liver, and kidney 
(Jang and Rabb, 2008). 
CXCL2 (MIP-2) is a chemokine that is in CXC family and chemotactic for 
neutrophils (Tarzami et al., 2001). MIP-2 is known to amplify inflammation in the 
kidney. Such chemokine activation would initiate leukocyte migration into renal 
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tissue and activate ICAM-1 to facilitate leukocyte adherence and infiltration 
(Behrends et al., 2007).  
The expression of MIP-2 upon exposure of cells to ischemia/hypoxia has recently 
been reported. MIP-2 expression has been shown to be induced in human microglia, 
cerebromicrovascular endothelial cells and astrocytes exposed to hypoxia. In renal 
ischemia reperfusion injury MIP-2 expression is upregulated (Tarzami et al., 2001). 
In post-ischemic tissues, chemokines are induced by reactive oxygen species (ROS), 
cytokines complement activation, TLR-mediated pathways, and the IL-8/CXCL8, 
human analog of rat CXCL2, plays a crucial role in neutrophil recruitment in the 
post-ischemic kidney mediating tissue injury via cytokines, free radical 
intermediates, and proteases.  IL-8 expression was reported to be increased during 
reperfusion of living and cadaveric donor kidney allografts in a clinical study and its 
expression correlated with the ischemic time imposed on the allograft. Growth-
related oncogene (GRO)-α/keratinocytederived chemokine (KC, a mouse analog of 
human IL-8) was induced in a murine ischemic acute kidney injury model. 
Neutralization of GRO-α/KC and macrophage inflammatory protein (MIP)-2 was 
reported to attenuate acute kidney injury. KC, the analog of rat CXCL2 is also an 
attractive early biomarker of acute kidney injury based on both murine and human 
studies (Jang and Rabb, 2008). 
CXC chemokines (i.e., IL-8 and homologues) are intricately involved in the process 
of neutrophil recruitment  with the functions of cellular adhesion molecules (Lentsch 
et al., 2000). 
Neutrophil accumulation was shown to be mainly mediated by the C-X-C chemokine 
MIP-2. Chronic hypoxia induces elevated levels of MIP-2 mRNA as part of a 
pronounced inflammatory response.  
Hypoxic MIP-2 induction occurs exclusively via the NF-kB pathway. NFkB plays a 
pivotal role in the induction of a variety of genes involved in immune and 
inflammatory responses. Increased NF-kB binding was observed under hypoxia 
(Zampetaki et al., 2004). 
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1.5 Reverse Transcriptase PCR (RT-PCR) 
In RT-PCR method, mRNAs are reverse transcribed into complementary DNA 
(cDNA) which is then amplified by PCR, and analyzed by agarose gel 
electrophoresis. RT-PCR (reverse transcription-polymerase chain reaction) is one of 
the available techniques for mRNA detection and quantification. Compared to  
Northern blot analysis, RT-PCR can be used to quantify mRNA levels from much 
smaller samples (Dharmaraj, 2007).  
However, this technique is semi-quantitative. After agarose gel electrophoresis, the 
PCR products become visible and can be quantified. 
The application of RT-PCR involves cloning  mRNA sequences in the form of 
complementary DNA, and allowing libraries of cDNA (cDNA libraries) to be created 
which contain all the mRNA sequences of genes expressed in a cell. Furthermore, 
this method allows the creation of cDNA constructs cloned by RT-PCR and enables 
the expression of genes at the RNA and protein level for further study. (―Reverse 
Transcription Polymerase Chain Reaction‖, 25 March 2009).  
1.5.1 Touch Down PCR 
Touchdown PCR is modification of conventional PCR that may result in a reduction 
of nonspecific amplification (Prilusky, 2004). The annealing temperature is 
decreased in increments for every subsequent set of cycles. The primer will anneal at 
the highest temperature. The amplification at high temperatures involves the most 
specific binding. Thus, this fragment will be amplified at lower temperatures. It will 
avoid the nonspecific binding at lower temperatures. 
1.5.2 Gradient PCR 
Gradient PCR can be used for the determination of optimum annealing temperature. 
It is a technique that allows the empirical determination of an optimal annealing 
temperature using the least number of steps. This optimization can often be achieved 
in one experiment (Prezioso et al., 2000). 
1.5.3 Multiplex PCR 
Multiplex polymerase chain reaction (PCR) is a variant of PCR in which two or more 
target sequences can be amplified by including more than one pair of primers in the 
same reaction. Since it was first described in 1988, this method has been successfully 
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applied in many areas of DNA testing, including gene deletion analysis , mutation 
and polymorphism analysis, quantitative analysis, and reverse- Transcriptase (RT)-
PCR (Markoulatos et al., 2002). The internal control gene and the gene of interest 
can be amplified in the same tube. Control gene products are required for the 
maintenance of the basal cellular function and are constitutively found in all human 
cells. These genes are also called housekeeping genes. Housekeeping  genes can be 
used to calibrate measurements of gene expression (Eisenberg and Levanon, 2003). 
The conditions will be the same for internal control and gene of interest in multiplex 
reaction. 
1.6 Real-Time PCR 
Real Time PCR has established itself as the most sensitive and specific quantitative 
PCR method (Dorak, 2006). It allows quantification of rare transcripts and small 
changes in gene expression. Generally two quantification types in real-time RT-PCR 
are possible. (i) a relative quantification based on the relative expression of a target 
gene versus a reference gene. To investigate the physiological changes in gene 
expression, the relative expression ratio is adequate for the most purposes (Pfaffl, 
2001).  (ii) absolute quantification calculates the copy number of the gene usually by 
relating the PCR signal to a standard curve (Schmittgen and Livak, 2008). Real-Time 
PCR applications are gene expression analysis, microarray result validation, gene 
knock-down result validation, specific analysis of oncological or virological research 
parameters, food pathogens and spoilage test, screening for genetically modified 
organisms, SNP genotyping and mutation detection (Roche Diagnostics Corporation, 
26 march 2009).  
Real-time PCR is a powerful tool to quantify gene expression. Some examples of 
quantitative gene expression studies include: as a validation of protein levels; as a 
validation of the extent of transcription of a gene; to study the difference in 
expression of a gene in the diseased state compared to the normal state; change in 
gene expression during cell differentiation or development; change in expression for 
cells that are exposed to a chemical substance (e.g., drug, toxin, hormone or 
cytokine) ; quantification of noncoding RNA gene expression; to validate the 
effectiveness of small interfering RNA or antisense oligonucleotides; and as a 
diagnostic tool (Schmittgen and Livak, 2008). 
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Real-time PCR is a very promising quantitative method based on the concept of 
monitoring the PCR reaction in the thermal cycler as it progresses (Marone et al., 
2001). However, this technique requires a relatively large amount of cDNA when 
compared with semi quantitative RT-PCR. 
The quantitative endpoint for real-time PCR is the threshold cycle (CT). The CT is 
defined as the PCR cycle at which the fluorescent signal of the reporter dye crosses 
an arbitrarily placed threshold. By presenting data as the CT, one ensures that the 
PCR is in the exponential phase of amplification. The numerical value of the CT is 
inversely related to the amount of amplicon in the reaction (i.e., the lower the CT, the 
greater the amount of amplicon) (Schmittgen and Livak, 2008). Error and efficiency 
are also important for Real-time PCR applications. Error must be below 0.2 and 
efficiency must be between 1.8 and 2.2. Efficiencies and errors of genes and internal 
control are calculated by standard curves with dilution series of undiluted, 1/10, 
1/100 and 1/1000 diluted samples. ΔΔCt is a method used for relative quantification. 
The advantage of using the comparative CT method is that the need for a standard 
curve is eliminated in each run. This increases throughput because wells no longer 
need to be used for the standard curve samples. It also eliminates the adverse effect 
of any dilution errors made in creating the standard curve samples (Pfaffl, 2005). 
1.7 Aim of the Study 
The aim of the study was to investigate the effects of ischemia reperfusion, IP and 
HP on DUSP1 and CXCL2 gene expression in rat kidney tissues using rt-PCR and 
real-time q-PCR. Gene expression analysis was performed using RT-PCR and 
quantitative real-time PCR. These two methods were compared with previously 
obtained microarray results. Particularly the expression changes upon heat 
preconditioning, ischemic preconditioning and only ischemia reperfusion injury were 
analyzed. For all three groups, the duration of ischemia was 45 min but reperfusion 
time was varied between 0 and 60 min. Thus, the effect of reperfusion time on gene 
expression was also studied and compared for each group. 
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2.  MATERIALS AND METHODS 
2.1 Materials and Laboratory Equipment Used 
2.1.1 Equipments Used 
Balances     Precisa BJ 610C (Switzerland)  
                   Precisa 620C SCS (Switzerland) 
Centrifuges     Beckman
® 
Coulter Microfuge (USA) 
Deep Freezers and Refrigerators  -80°C Heto Ultrafreeze 4410 (Denmark) 
-20°C Arçelik (Turkey)   
+4°C Arçelik (Turkey) 
Electrophoresis equipments   E-C Minicell
®
 primo EC320(USA) 
                                                E-C Midicell
® 
Primo EC330 (USA) 
Gel Documentation System UVI PhotoMW Version 99.05 for 
Windows 
Magnetic Stirrer    Magnetic stirrer standard unit (Germany) 
Ultrapure Water System   USF-Elga UHQ (USA) 
PCR      Techne TC–412 (England) 
Micropipettes     Eppendorf (Germany)  
Real time PCR equipment   Roche Lightcycler 2.0 
Transilluminator     Biorad UV Transilluminator 2000 
Vortex      Heidolph Reax top 
2.1.2 Chemicals, Enzymes, Markers and Buffers Used 
2.1.2.1 Chemicals 
Agarose       AppliChem 
Boric acid       Amresco 
EDTA        AppliChem 
EtBr        Amresco 
NaOH        Riedel-de Haën 
Primers(Real-Time PCR)     IDT DNA 
Primers (RT-PCR)      Genova 
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2.1.2.2 Enzymes 
Taq DNA Polymerase     Fermentas 
2.1.2.3 Markers 
Gene Ruler
TM
 100bp plus  DNA Ladder(SM 0323)  Fermentas 
 
Figure 2.1: Information on Gene Ruler
TM
 100bp plus  DNA Ladder (Fermentas). 
 
GeneRuler™ DNA Ladder Mix(SM 0333)    Fermentas 
 
 
Figure 2.2: Information on GeneRuler™ DNA Ladder Mix (Fermentas). 
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FastRuler™ DNA Ladder Low Range(SM 1103)   Fermentas 
 
 
 
Figure 2.3: Information on FastRuler™ DNA Ladder Low Range  (Fermentas). 
2.1.2.4 Buffers 
TBE (Tris-Borate-EDTA) Buffer (10X) 
Tris (hidroxymetyly) aminomethane   121.14 g  
Boric Acid      61.83 g 
EDTA       7.44 g 
Add ddH2O to 1 liter  
Mini Agarose Gel (1,5%)  
Agarose      0.9 g 
TBE buffer (1X)     60 mL 
Add 3 μL EtBr before pouring the gel into tray. 
Midi Agarose Gel (1%)  
Agarose      2.25 g 
TBE buffer (1X)     150 mL 
Add 7.5 μL EtBr before pouring the gel into tray. 
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2.1.3 Molecular Biology Kits Used 
cDNA synthesis kit  Roche – Transcriptor First Strand cDNA synthesis kit 
Real-Time PCR  Roche – LightCycler® TaqMan Master Kit   
 
RT-PCR Invitrogen-SuperScript
TM 
III One-Step RT-PCR      
System with Platinum
®
  Taq DNA Polymerase 
                                                         
2.1.4 RNA samples used in this study 
Male Wistar rats, 30 weeks old and 220-358 g in weight were used for analysis of 
gene expression patterns of CXCL2 and DUSP1 genes upon ischemia/reperfusion 
(I/R), with ischemic preconditioning (IP) and heat preconditioning (HP). The rats 
were anesthetized by intraperitoneal atropine, ketamin and rompun. The 
retroperitonium was visualized following abdominal dissection. Ischemia was 
performed by clamping the left kidney. Rats were subjected to  ischemia for 45 min 
followed by reperfusion. Heat shock was performed 24 hours before the ischemia by 
placing the rats at 42 
°
C for 5 min. Ischemic preconditioning was applied by 5 min of 
ischemia and 10 min of reperfusion for 3 cycles (Table 2.1). These procedures were 
done in Erlangen University. In this thesis work, RNA samples isolated from those 
rat kidney tissues previously were used.  
Eleven samples were chosen according to their RNA concentration values. 9 samples 
were ischemia reperfusion subjected rats and 2 samples were sham operated rats 
which were subjected to surgical manipulation, without the induction of renal 
ischemia, thus serving as control groups. 
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Table 2.1: RNA samples used in the study 
Sample 
No 
Samples name Explanation 
1 HP_I45_R0_A 
After heat preconditioning, rats were subjected to left 
renal ischemia for 45 min. 
 
3 HP_I45_R15_A 
After heat preconditioning, rats were subjected to left 
renal ischemia for 45 min followed by 15 min 
reperfusion 
 
5 HP_I45_R60_A 
After heat preconditioning, rats were subjected to left 
renal ischemia for 45 min followed by 60 min 
reperfusion 
 
14 I45_R0_B 
Rats were subjected to left renal ischemia for 45 min 
 
16 I45_R15_B 
Rats were subjected to left renal ischemia for 45 min 
followed by 15 min reperfusion 
 
18 I45_R60_B 
Rats were subjected to left renal ischemia for 45 min 
followed by 60 min reperfusion 
 
Table 2.1 (contd) :  RNA samples used in the study 
Sample 
No 
Samples name Explanation 
26 IP_I45_R0_B 
After ischemic preconditioning was applied, rats were 
subjected to left renal ischemia for 45 min. 
 
28 IP_I45_R15_B 
After ischemic preconditioning was applied, rats were 
subjected to left renal ischemia for 45 min followed by 
15 min reperfusion. 
 
29 IP_I45_R60_A 
After ischemic preconditioning was applied, rats were 
subjected to left renal ischemia for 45 min followed by 
60 min reperfusion. 
 
31 Sham A 
Rats were subjected to surgical manipulation without the 
induction of renal ischemia 
 
32 Sham B 
Rats were subjected to surgical manipulation without the 
induction of renal ischemia 
 
2.1.5 RNA isolation 
RNA isolation and microarray experiments were applied in Erlangen University as 
follows: RNA isolation was done with with peqGOLD TriFast
TM
. After treatment, 
total cellular RNA was extracted and pooled. RNA quality and quantity was assessed 
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using a Bioanalyzer 2100 (Agilent, Santa Clara, CA) and 6000NanoAssay (Agilent, 
Santa Clara, CA) (Table 2.2). High throughput gene expression profiling was 
performed using cDNA-microarrays (Affymetrix, Santa Clara, CA). Differentially 
expressed genes were further characterized in silico (Table 2.3). 
Table 2.2: Properties of RNAs 
Nr Samples Probe1 Probe2 
Mixture 
(µg) 
Concentr. 
in (µg/µl) 
A 
260/280 
µl 
1 HP_I45_R0_A A 53 a A 78 ca. 30 1.61 2.3 3 
3 HP_I45_R15_A A 73 b A 74 b ca. 30 1.57 2.32 21 
5 HP_I45_R60_A A 44 a A 43 ca. 30 1.97 2.27 7 
14 I45_R0_B A 14 A 18 ca. 30 1.55 1.42 4.5 
16 I45_R15_B A 35 A 36 a ca. 30 1.85 1.47 3.5 
18 I45_R60_B A 19 A 67 a ca. 30 2.32 1.62 5.5 
26 IP_I45_R0_B A 65 A 96 30 1.87 1.96 12 
28 IP_I45_R15_B A 60 a A 62 a 30 2.52 1.81 7 
29 IP_I45_R60_A B 55 B 56 30 1.80 1.64 7.5 
31 Sham_A A 39 a A 30 30 2.07 1.96 9 
32 Sham_B A 29 a A 42 30 2.25 2.27 10 
Table 2.3: Microarray results of DUSP1 and CXCL2 gene (Tektaş, 2006 and 
Yılmaz, 2009). 
SAMPLES 
DUSP1/shamA 
ratio 
DUSP1/shamB 
ratio 
CXCL2/shamA 
ratio 
CXCL2/shamB 
ratio 
HP-I45-R0-A (1) 
-1.27 
 
-1.51 
 
-0.18 0.14 
HP-I45-R15-A 
(3) 
-1.15 
 
-1.2 
 
-0.31 0.24 
HP-I45-R60-A 
(5) 
1.6 
 
1.47 
 
1.66 1.52 
I45-R0-B (14) 
-0.97 
 
-1.24 
 
0.03 -0.04 
I45-R15-B (16) 
-0.79 
 
-1.01 
 
-0.35 -0.16 
I45-R60-B (18) 
1.14 
 
1.18 
 
1.92 1.94 
IP-I45-R0-B (26) 
1.06 
 
1.19 
 
1.49 1.53 
IP-I45-R15-B 
(28) 
1.2 
 
1.1 
 
0.91 1.01 
IP-I45-R60-A 
(29) 
1.05 
 
1 
 
1.44 1.52 
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2.2 RT-PCR 
PCR was used to amplify the target DNA sequences on CXCL2 and DUSP1 gene. 
RNAs were used as templates. Reverse transcription of mRNA samples and 
amplification steps were performed by SuperScript
TM 
III One-Step RT-PCR System 
involving SuperScript
TM 
III RT/ Platinum
®
 Taq DNA polymerase enzyme complex. 
A standard PCR mixture was used to amplify sequences of CXCL2 and DUSP1 
gene. RNA sample concentrations were determined previously as (µg/µl). RNA 
template concentrations that were used for PCR were determined in ng range and 
1:10 dilutions were applied (Table 2.4, 2.5, 2.6 and 2.7). The template amounts of 
CXCL2 multiplex experiment were determined as twice of the other experiments.  
Table 2.4:  PCR mix of heat preconditioning samples for rt-PCR 
Heat Preconditioning 
Ingredients Volume (µl) 
 Sample No 
1 
Sample No 
3 
Sample No 
5 
dH2O 20.48 20.47 20.59 
Reaction mix
1
 25 25 25 
Primer of gene 1 1 1 
Primer of β-actin 1 1 1 
Template 0.62 0.63 0.51 
Superscript III RT/Platinum Taq Mix 1.9 1.9 1.9 
FINAL Volume 50 µl 50 µl 50 µl 
 
Table 2.5:  PCR mix of Ischemia Reperfusion samples for rt-PCR 
Ischemia Reperfusion 
Ingredients Volume (µl) 
 Sample No 
14 
Sample No 
16 
Sample No 
18 
dH2O 20.56 20.67 20.57 
Reaction mix 25 25 25 
Primer of gene  1 1 1 
Primer of β-actin 1 1 1 
Template 0.54 0.43 0.53 
Superscript III RT/Platinum Taq Mix 1.9 1.9 1.9 
FINAL Volume 50 µl 50 µl 50 µl 
 
                                                 
1
 The 2X Reaction Mix included in the kit consists of a proprietary buffer system that has been optimized for 
reverse transcription and PCR, Mg2+, dNTPs, and stabilizers. 
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Table 2.6:   PCR mix of  Ischemic  preconditioning and Sham samples for rt-PCR 
 Ischemic Preconditioning Sham 
Ingredients Volume(µl) 
 Sample 
No 26 
Sample 
No 28 
Sample 
No 29 
Sham 
A 
Sham 
B 
dH2O 20.57 20.70 20.54 20.62 20.65 
Reaction mix 25 25 25 25 25 
Primer of gene  1 1 1 1 1 
Primer of β-actin 1 1 1 1 1 
Template 0.53 0.40 0.56 0.48 0.45 
Superscript III RT/Platinum 
Taq Mix 
1.9 1.9 1.9 1.9 1.9 
FINAL Volume 50 µl 50 µl 50 µl 50 µl 50 µl 
Table 2.7: PCR mix of Sham A, Sham B and Sample 28 with only β-actin primers 
for rt-PCR 
Controls 
Ingredients Volume(µl) 
 ShamA            
(with only β-actin) 
ShamB                       
(with only β-actin) 
Sample 28 
(with only 
β-actin) 
dH2O 21.62 21.65 21.70 
Reaction mix 25 25 25 
Primer of  β-actin 1 1 1 
Template 0.48 0.45 0.40 
SuperscriptIII 
RT/Platinum Taq Mix 
1.9 1.9 1.9 
FINAL VOLUME 50 µl 50 µl 50 µl 
2.2.1 Oligonucleotide primers 
Complementary DNA sequences of CXCL2  and DUSP1 genes were used for primer 
design via ―Primer 3‖ and ―Amplify 3‖ softwares. The primer sets were analyzed for 
dimer formation, non-specific binding and hairpin formation. 
Table  2.8: Oligonucleotide primers used in the RT-PCR experiments in this study 
Gene Primer Primer Sequence 
Tm 
(˚C) 
GC% 
Product 
Size 
(bp) 
DUSP1 
PrimerF TGAAGCAGAGGCGGAGTATT 60.0  50.0  
222 bp 
PrimerR TGATGGGGCTTTGAAGGTAG 60.1  50.0  
CXCL2 
Primer3F AGGGTACAGGGGTTGTTGTG 59.7 55.0  
179 bp 
Primer3R GGCTTCAGGGTTGAGACAAA 60.2  50.0  
Β-actin 
FPrimer TTGCTGACAGGATGCAGAAG 60.14 50.0 
122 bp 
RPrimer CAGTGAGGCCAGGATAGAGC 59.97 60.0 
CXCL2 
(second 
primer) 
Primer4F CAGGGTACAGGGGTTGTTGT 59.7  55.0  
180 bp Primer4R GGCTTCAGGGTTGAGACAAA 60.2  50.0  
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2.2.2 PCR conditions 
The PCR condition for DUSP1 gene are  shown in Table 2.9. 
Table 2.9: PCR conditions for DUSP1 gene 
Phase 
Temperature 
(°C) 
Time Cycle Number 
cDNA synthesis 55 30 min 1 
Initial Denaturation 94 2 min 1 
Denaturation 94 15 sec 
32 Annealing 53 90 sec 
Extension 68 50 sec 
Final Extension 68 5 min 1 
The PCR condition for CXCL2 gene are  shown in Table 2.10. 
Table 2.10:  PCR conditions for CXCL2 gene 
Phase 
Temperature 
(°C) 
Time 
Cycle 
Number 
cDNA synthesis 55 30 min 1 
Initial Denaturation 94 2 min 1 
Denaturation 94 15 sec 
35 Annealing 58 30 sec 
Extension 68 30 sec 
Final Extension 68 5 min 1 
2.2.3 PCR cycle conditions 
Optimum PCR cycle conditions were determined both for CXCL2 and DUSP1 
genes. HP_I45_R15_A sample was used for determining the optimal PCR cycle 
number. The optimum cycle number was determined by comparing the band values 
of  23., 26., 29., 32., 35., 38., and 40
th
 cycles. Ten µl PCR mix was withdrawn by 
stopping reaction at 23., 26., 29., 32.,  35., 38., and 40th cycles. Bands were observed 
in 1.5% agarose gels. Densitometric analysis of the PCR products of these cycles 
were performed by using ―Biocapt Software‖ (Vilber-Lourmat, Marne LaValle, 
France).  
2.2.4 PCR optimization 
PCR reactions generally need to be optimized. The optimization can be done by 
determination of appropriate annealing temperature, annealing time, extension 
temperature and extension time. Amplification of correct sequence, correct primer 
sets and appropriate cycle numbers and Mg concentrations are also important 
parameters for optimization. Different primer sets; different annealing temperatures 
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and time; different extension temperatures and time; gradient PCR and touch-down 
PCR were used for PCR optimization throughout this study (Table 2.11 and 2.12) 
DUSP1 gene optimization was performed with sample number 3, 18, 26 by 
comparing 23., 26., 29., 32., 35., 38., and 40
th
 cycles. PCR amplification was 
conducted as follows: 55 
°
C (30 min) for cDNA synthesis, 94
 °
C (2 min) for initial 
denaturation and then 32 cycles at 94
 °
C (15 sec) / 53
 °
C (90 sec) / 68
 °
C (50 sec) and 
a final extension at 68
 °
C (5 min). 
CXCL2 gene optimization was performed with sample number 3. DNA 
contamination experiment and control of primer dimers were firstly done. DNA 
contamination experiment was carried out with 0.4 µl Taq DNA polymerase (2 units) 
instead of Superscript III RT/Platinum Taq Mix. All of the samples were controlled. 
Control of dimers was done again  with 0.4 µl Taq DNA polymerase (2 units). PCR 
reaction mixtures containing only one primer of each primer pairs and both primers 
of the primer pairs for CXCL2 were prepared. Each forward and reverse primers  
were diluted at the ratio of  1:10. All primers had a final concentration of 10 µM. 
Table 2.11: Temperature and time optimizations of CXCL2 for rt- PCR 
 
1.primer 
PCR type 
Annealing Extension Sample that is 
used 
(Number) 
Temperature 
°C 
Time 
(sec) 
Temperature 
°C 
Time 
(sec) 
RT-PCR 56 30 68 30 HP_I45_R15_A(3)  
RT-PCR 60 30 68 30 HP_I45_R15_A(3) 
Gradient 
PCR 
55  -65 30 68 30 HP_I45_R15_A(3) 
RT-PCR 58 30 68 30 HP_I45_R15_A(3) 
RT-PCR 62 20 68 50 HP_I45_R15_A(3) 
RT-PCR 62 10 68 50 HP_I45_R15_A(3) 
RT-PCR 60 40 68 10 HP_I45_R15_A(3) 
RT-PCR 62 30 68 11 HP_I45_R15_A(3) 
1,8 mM and 
2 mM 
MgSO4 
62 30 68 50 HP_I45_R15_A(3) 
62 20 68 30 HP_I45_R15_A(3) 
62 20 68 50 HP_I45_R15_A(3) 
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Table 2.12: Temperature and time optimizations of CXCL2 for rt- PCR 
2. 
Primer 
PCR type 
Annealing Extension 
Sample that is used 
(Number) 
Temperature 
(°C) 
Time 
(sec) 
Temperature 
(°C) 
Time 
(sec) 
RT-PCR 53 90 68 50 HP_I45_R15_A(3) 
RT-PCR 56 30 68 50 HP_I45_R15_A(3) 
Gradient 
PCR 
55-65 30 68 30 HP_I45_R15_A(3) 
RT-PCR 64 30 68 30 HP_I45_R15_A(3) 
Touch-
down PCR 
63-48 30 68 30 HP_I45_R15_A(3) 
Touch-
down PCR 
70-64 30 68 30 
HP_I45_R15_A(3)& 
I45_R60_B(18) 
Touch-
down PCR 
70-64 30 68 20 HP_I45_R15_A(3) 
1,8 mM 
and 2 mM 
MgSO4 
64 30 68 50 HP_I45_R15_A(3) 
2.2.5 Touchdown PCR 
Three different touchdown PCR optimization experiments were performed using the 
second primer set of CXCL2 gene. 
The first touchdown PCR program involved decreasing the annealing temperature  
by 1 
0
C at every  cycle from  63 
°
C to a touchdown of 48 
°
C  (30 sec) at which 11 
cycles were carried out. 
The second Touch Down PCR experiment was carried out according to the following 
program: 55
 °
C (30 min) for cDNA synthesis, 94 
°
C (2 min) for initial denaturation 
and then 40 cycles at 94 
°
C (15 sec), the annealing temperature was decreased  by 1   
°
C at every  cycle from  70 
°
C to a touchdown of 64 
°
C  (30 sec) at which 35 cycles 
were carried out; 68 
°
C (30 sec) and a final extension at 68 
°
C (5 min). 
The third Touch Down PCR experiment was different from the second touchdown 
PCR only by extension time. Extension time was reduced from 30 seconds to 20 
seconds. 
2.2.6 Gradient PCR 
Eleven tubes of the same PCR were run using a thermocycler with different 
annealing temperatures. The total reaction volume in each tube was 25 µl. 
Gradient PCR was used to optimize the annealing temperature of CXCL2 gene by a 
gradient from 65 °C to 55 °C with first and second primer sets. 
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2.2.7 Multiplex PCR 
The PCR reactions of DUSP1 and CXCL2 gene were performed with two primer 
sets. One set belonged to the gene of interest, either DUSP1 or CXCL2, and the other 
to the internal control gene, which was chosen as beta actin throughout this study as 
a housekeeping gene in eukaryotes (Thellin et al., 1999). 
2.3 Agarose Gel Electrophoresis of PCR Products 
The DNA bands belonging to the PCR products were visualized on a 1.5 % agarose 
gel. 1.5 % mini or midi gels were prepared. Mini gels were prepared with 0.9 g 
agarose and 3 μl ethidium bromide added into 60 mL of 1X TBE buffer, which was 
diluted from 10X stock TBE solution. Midi gels (1.5 % ) were prepared with 2.25 g 
agarose and 7.5 μL ethidium bromide added into 150 mL of 1X TBE buffer. 10 μL of 
PCR product was mixed with 5 μL 1X loading dye and loaded into the wells. 
GeneRuler™ 100bp Plus marker (Fermentas) was used as DNA ladder. The gels 
were run in 1X TBE buffer, at 100V for  30 min, and observed under UV light using 
a transilluminator. Gel images were obtained using UV PhotoMW software. 
2.4 Real  Time PCR 
2.4.1  cDNA synthesis 
cDNA was synthesized from isolated total RNA by using Transcriptor First Strand 
cDNA Synthesis Kit  (Roche). 
The protocol used for Transcriptor First Strand cDNA synthesis Kit from Roche is as 
follows: template-Primer Mix components were prepared firstly using the 
components shown in Table 2.13. Reverse transcription can be done using either 
anchored-oligo (dT)18 primer or random hexamer primer. Random hexamer primer 
was chosen. 
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Table 2.13 : Template-Primer Mix components 
Template-PCR mix 
Component Volume (µl) Final Concentration 
Total RNA (ng) 
1 1 ng up to 4 µg 
 
Anchored oligo (dT)18 primer, 50 
pmol/μL 
- 2.5 µM 
 
or random hexamer primer,600 
pmol/μL 
2 60 µM 
 
Water, PCR grade 8.4  
Total Volume 11.4  
 
After preparing template-primer mix, the template-primer mixture was denatured by 
heating the tube at 65°C for 10 min in a thermal cycler with a heated lid to minimize 
evaporation. This step ensured denaturation of  RNA secondary structures. After this 
step, the mixture was immediately transferred onto ice. 
Remaining components of RT mix were added as in the order given in Table 2.14. 
Table 2.14 : The volumes of the remaining components of the RT mix 
Component 
 
Volume 
(µl) 
Final concentration 
 
Transcriptor High Fidelity Reverse 
Transcriptase Reaction Buffer, 5× 
concentrated 
 
4 
1× 
(8 mM MgCl2) 
 
Deoxynucleotide Mix, 10 mM each 2 
 
1 mM each 
 
 
Protector RNase Inhibitor, 
40 U/µl 
 
0.5 
20 U 
 
DTT 
 
1 
5 mM 
 
Transcriptor High Fidelity Reverse 
Transcriptase 
 
1.1 
10 U 
 
After preparing the second mixture by adding these five components, the template-
primer mixture was removed from the thermal cycler and the RT mixture was added 
to it to make the total volume 20 µl. The components were mixed well by pipetting 
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and the tubes were spinned  in a microfuge. Thereafter, the tubes were placed into 
thermal cycler again. The mixture was incubated at 50 °C for 30 min. Transcriptor 
High Fidelity Reverse Transcriptase was inactivated by heating to 85 °C for 5 min. 
The reaction was then stopped by placing the tubes on ice. The synthesized cDNAs 
were stored at  -20 °C for later use. cDNAs of 11 samples were synthesized 
according to this protocol. 
2.4.2 Real-Time PCR conditions 
LightCycler TaqMan Master Kit (Roche) was used for Real-Time PCR. The reaction 
was performed using Roche LightCycler
®
 2.0 equipment. Master mix was prepared 
according to LightCycler TaqMan Master Kit instructions (Roche). Total volume of 
10 µl from FastStart Taq DNA Polymerase was pipetted into Reaction Mix. This 
mixture was called LightCycler® TaqMan® Master. Twenty µM solutions of the 
PCR primers were prepared. Twenty µl was withdrawn from 100 µM primer 
solutions and 80 µl water was added. The order of adding components is indicated  in 
the Table 2.15. 
Table 2.15: Real-Time PCR Mix for a 20 µl reaction volume 
Component Concentration 
Volume 
(µl) 
Final 
Concentration 
Water, PCR-grade 
 
 9   
Primer Mix (UPL Ref. Gene 
Assay) 
 
20 µM 0.4  200 nM 
Primer (Gene of Interest-GOI) 
forward 
 
20µM 0.4  200 nM 
Primer (GOI) reverse 
 
20µM 0.4  200 nM 
Probe (UPL Ref. Gene Assay) 10µM 0.4  400 nM 
UPL probe (GOI) 
 
10µM 0.4  400 nM 
LightCycler® TaqMan® Master 5X 4  1X 
 
The components were mixed gently by pipetting up and down and were not vortexed. 
Fifteen µl PCR mix was pipetted into each precooled LightCycler® Capillary and 5 
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µl of the cDNA template was added. At the end, each capillary was sealed with a 
stopper. Five tubes for the standard curve: undiluted; 1:10 diluted; 1:100 diluted; 
1:1000 diluted; and negative control were prepared. Two µl cDNA was used for 
undiluted sample. Dilutions were made both for β-actin and for the samples. Before 
placing the tubes into the real-time PCR instrument, they were centrifuged at 2000 
rpm for 1 min in a benchtop centrifuge.  
2.4.3 Selection of Primers and probes  
Probes and primers that were used in this thesis were selected from Universal Probe 
Library (Roche) according to manufacturer‘s instructions. Probe 85 was used for 
CXCL2 gene and Probe 17 was used for DUSP1 gene (Table 2.16). 
Table 2.16: Real-time PCR primers selected from Universal Probe Library (Roche)        
according to probes 
Primer 
 
Length 
 
Position 
 
Tm 
(°C) 
%GC 
 
Sequence 
 
Amplicon 
 
CXCL2 
Left 
 
23 
 
333-355 
 
59 
 
43 
 
ggatcgtccaaaagatactgaac 
 
72 nt 
CXCL2 
Right 
 
21 
 
 
384-404 
 
60 
 
52 
 
ggtacaggagcccatgttctt 
 
DUSP1  
Left 
 
20 
 
597-616 
 
59 
 
55 
 
gtgcctgacagtgcagaatc 
 94 nt 
 
DUSP1 
Right 
20 
 
671-690 
 
59 
 
60 
 
ccaggtacaggaaggacag 
 
Water had to be added to the primers and Integrated DNA Technologies homepage 
was used to calculate the water volume to be added. Water resuspension volumes of 
DUSP1 and CXCL2 primers were calculated according to manufacturer‘s 
instructions provided with the primers (Table 2.17). 
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Table 2.17: The volume of water that has to be added to each primer to reach 100 
µM concentration 
Gene Water volume to be added (µl) 
DUSP1 R 668  
DUSP1 L 
 
650.1  
 
CXCL2 R 
714.6  
 
CXCL2 F 
933  
 
Primer solutions of 100 µM were prepared. Reverse and forward primers were not  
mixed together to avoid dimer formation. Primers were vortexed very shortly (four 
times),  but probes were not vortexed and they were stored  in dark . 
The package inserts files were downloaded from Roche‘s homepage. Real-time PCR 
Protocol for use with LightCycler® TaqMan® Master protocol was obtained from 
the package inserts files. Table 2.18 shows the PCR parameters that must be 
programmed for a LightCycler® Carousel-based System PCR run with the 
LightCycler® Taq- Man® Master. 
Table 2.18: PCR parameters for a LightCycler® Carousel-based System PCR run 
with the LightCycler® Taq- Man® Master. 
Analysis Mode Cycles 
Target 
Temperature 
(°C) 
Hold 
Time 
Acquisition 
Mode 
Pre-Incubation 1 95 10 min None 
Amplification 45 
95 10 sec None 
60 30 sec None 
72 1 sec single 
Cooling 1 40 30 sec None 
 
The protocol for a Universal Probe Library assay using the LightCycler TaqMan® 
Master consists of the following parts: pre-Incubation for activation of FastStart Taq 
DNA Polymerase and denaturation of the DNA, amplification of the target cDNA 
and cooling the rotor and thermal chamber. 
In a multicolor reaction, the wavelengths of light emitted by the dyes overlap, 
causing one channel to pick up signals from a dye measured by another channel. This 
bleed-over of fluorescence signal can result in uninformative data. Color 
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compensation experiment is applied to correct the bleed-over (Roche Applied 
Science). Channel 530 was used for CXCL2 and DUSP1 gene, channel 560 for β-
actin. Both channels were selected during analyses. 
2.4.4 Properties of the probes 
A good example for selection of probes is the use of ― Universal Probe Library‖ of 
Roche . Universal ProbeLibrary is based on only 165 short hydrolysis probes, labeled 
at the 5' end with fluorescein (FAM) and at the 3' end with a dark quencher dye.  
Locked Nucleic Acids (LNA) are incorporated into the sequence of each UPL probe 
in order to maintain the specificity and melting temperature that hybridizing qPCR 
probes require (Roche Diagnostics Corporation, 26 march 2009). 
         LNA‘s are bicyclic DNA nucleotide analogues with increased binding strengths 
compared to standard  DNA nucleotides. For this reason, LNA- based probes need to 
be only 8–9 bases long to achieve a Tm of 68 °C - 69°C under standard conditions 
(Dorak, 2005). 
2.4.5 Real time PCR optimization 
Table 2.19: The experiments conducted for real time PCR optimization 
Gene 
The sample that is 
used, 
 (sample number) 
Type of assay Dilution series 
DUSP1 HP_I45_R15_A (3) multiplex 
undiluted, 1/10, 
1/100 , 1/1000 
CXCL2 HP_I45_R15_A(3) multiplex&singleplex 
undiluted, 1/10, 
1/100 , 1/1000 
CXCL2 HP_I45_R15_A(3) multiplex&singleplex 
undiluted, 1/10, 
1/100 , 1/1000 
CXCL2 HP_I45_R15_A (3) multiplex&singleplex 
undiluted, 1/10, 
1/100 , 1/1000 
CXCL2 Sham B multiplex 
undiluted, 1/10, 
1/100 , 1/1000 
CXCL2 Sham B singleplex 
undiluted, 1/10, 
1/100 , 1/1000 
CXCL2 HP_I45_R15_A (3) multiplex&singleplex 
Undiluted, 1/2 , 
1/4 , 1/8 
The first real time PCR optimization for DUSP1 gene optimization was done with  
DUSP1 gene as multiplex assay with dilution series of undiluted, 1/10, 1/100, 1/1000 
to calculate the efficiency and the error of DUSP1 and β-actin. The standard curve 
experiment was set with sample number 3 (HP_I45_R15_A) (Table 2.19). 
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Real time PCR optimization experiments for CXCL2 gene were done as singleplex 
and multiplex assays (Table 2.19). The compositon of multiplex assay mixtures were 
shown in Table 2.15. Singleplex assay components are given in Table 2.20. 
Table 2.20: Components of Singleplex assay 
Components Volume (µl) 
Water, PCR-grade 10.4  
Primer (GOI) forward 
 
0.2  
Primer (GOI) reverse 
 
0.2 
UPL probe (GOI) 0.2  
LightCycler® TaqMan® Master, 4  
TOTAL VOLUME 15  
Four of the PCR optimization  experiments of CXCL2 gene were done using sample 
3 (HP_I45_R15_A). Two of them were done using Sham B which has higher RNA 
concentration than sample 3. Dilution series of undiluted, 1/10 , 1/100 , and  1/1000 
dilution samples were prepared with 2 µl cDNA. Dilution series of undiluted, 1/2, 
1/4, and 1/8 diluted samples were done using 10 µl cDNA(Table 2.19). 
Primer and probe volumes of CXCL2 gene were increased from 0.4 µl to 0.6 µl 
using sample 16 (I45_R15_B). 
2.5 Expression Analysis 
2.5.1 Relative Quantification of the Samples of RT-PCR 
The volumes of PCR products of all samples were calculated by using ―Biocapt 
Software‖ (Vilber-Lourmat, Marne LaValle, France). After the volume of DUSP1 
and β-actin bands were calculated for each sample, log2 values of the results were 
calculated. The logaritmic results of DUSP1 gene expression were normalized with 
logaritmic results of β-actin gene expression by dividing DUSP1 results by β-actin 
results. These results were then divided by the logarithmic results of Sham A and 
Sham B (controls). The resulting ratios indicate the relative expression levels of each 
sample. These calculations were applied also for CXCL2 gene. 
2.5.2 Relative quantification of the samples of Real-Time PCR 
The relative quantification of the samples was done by 2
-ΔΔCT 
method (Schmittgen 
and Livak, 2001). Sham A and Sham B were chosen as calibrators. The gene 
expression changes were calculated according to calibrators.  ΔCT  value of  DUSP1 
  
39 
and CXCL2 were calculated by normalizing the average Ct values of the genes via 
subtracting  the average  Ct value of β-actin. ΔCT value of calibrators were subtracted 
from ΔCT value of genes and ΔΔCT value was obtained for Sham A and Sham B, 
separately. The minus value of  ΔΔCT value was placed as the power of 2.  2
-ΔΔCT
  
gave the relative quantification of the genes. 
2.6 Statistical Analysis 
The Friedman two-way analysis of variance by ranks (Friedman (1937)) is employed 
with rank-order data in a hypothesis testing situation involving a design with two or 
more dependent samples (Sheskin, 2004). Friedman test can also be defined is a 
distribution-free nonparametric test ANOVA for a randomized block design when 
comparing k treatments for significant difference among the means (Deep, 2006). It 
is used to detect the differences between multiple groups. The procedure involves 
ranking for each row, then considering the values of ranks by columns.  
Assumptions of Friedman test: i) The samples from the k populations must be 
dependent (Glenberg and Andrzejewski, 2007), ii) The data to be analyzed are 
continuous and at least ordinal level of measurement, iii) The data from a randomly 
selected sample are either a) multiple observations from a single sample across more 
than two time periods or conditions or b) blocks of matched subjects in which the 
subjects from a given block are each randomly assigned to one of the three or more 
conditions (Pett, 1997).  
The formula of Friedman test is:  
Fr =                                                                             (2.1)   
where b= the number of the blocks, k= the number of rows, Rj= sum of the ranks in 
the jth column, and Fr = Friedman test statistic. 
Friedman Test is used to test the relationship between the results of RT-PCR, Real-
time PCR and microarray with the program SPSS (version 13). Hypothesis testing is 
the process of inferring from a sample whether or not to accept a certain statement 
about the population. The statement itself is called the hypothesis. The hypothesis to 
be tested is called the null hypothesis and is denoted by Ho. The alternative 
hypothesis, denoted by H1, is the negation of the null hypothesis, and usually consists 
of a statement equivalent to saying Ho is not true (Conover, 1998). The p value of a 
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test is the critical boundary between acceptance and rejection of null hypothesis 
(Deep, 2006). α (level of significance) is the maximum probability of rejecting a true 
null hypothesis (Conover, 1998). α is decided to be chosen as 0.01. 
The hypothesis used in this thesis are as follows: 
Ho: There is no significant difference between the results of three methods. 
H1: There is significant difference between the results of three methods. 
Reject Ho (the null hypothesis) if p value < α; p < 0.01 
Accept Ho (the null hypthesis) if p value > α; p > 0.01 
Kendall‘s coefficient of concordance, developed independently by Kendall, and 
Babington-Smith (1939) and Wallis (1939), is a measure of correlation/association 
that is employed for three or more sets of ranks and  allows researcher to evaluate the 
degree of agreement between m sets of ranks for n subjects/objects. The parameter 
estimated by the correlation coefficient will be represented by the notation W. The 
range of the possible values within which Kendall‘s coefficient of concordance may 
fall is 0<W<1. When there is a complete agreement among all m sets of ranks, the 
value of W will be 1. When there is no pattern of agreement among m sets of ranks, 
W will be 0. Friedman test and Kendall‘s coefficient of concordance are based on the 
same statistical model (Sheskin, 2004). Kendall‘s coefficient of concordance can be 
used in the same situation where Friedman test statistic is applicable although it was 
probably intended primarily as a measure of ―agreement in rankings‖ in the rows, 
rather than as a test statistic (Conover, 1998). 
If  W < 0.70 the results of the methods are unrelated. 
W > 0.70 the results of the methods are related. 
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3. RESULTS 
3.1 RT-PCR 
3.1.1 Optimization of PCR cycle number for DUSP1 and CXCL2 
PCR products‘ amplicon size of CXCL2 is 179 bp with the first primer set, 180 bp 
with the second primer set and DUSP1 is 222 bp. 
Oligonucleotide primer set of DUSP1 gene resulted in successful PCR 
amplifications. However, the first primer set of CXCL2 gene did not give good PCR 
results. Although the band of CXCL2 gene (179 bp) was observed, there was a 
nonspecific  band between 200 and 300 bp. The second best primer set suggested by 
Primer 3 and Amplify 3 softwares was tested for the next experiments. The 
nonspecific band  was still observed in agarose gels. 
Before starting with the rt-PCR experiment, optimization was done for cycle 
numbers for each of the two genes, DUSP1 and CXCL2. The results for DUSP1 gene 
are shown in Figure 3.1. The optimum cycle number was observed as 32 for DUSP1. 
Thus the following PCR program was used in the rt-PCR experiments: 55 
°
C (30 
min) for cDNA synthesis, 94 
°
C (2 min) for initial denaturation and then 32 cycles at 
94
 °
C (15 sec) / 53
 °
C (90 sec) / 68
 °
C (50 sec) and a final extension at 68
 °
C (5 min). 
 
Figure 3.1: Optimization of PCR cycle number for DUSP1 
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Table 3.1: Explanation of  bands in Figure 3.1 
Lane Explanation Lane Explanation 
1 Marker 5 32
nd
 cycle 
2 23
rd
 cycle  6 35
th
 cycle 
3 26
th
 cycle 7 38
th
 cycle 
4 29
th
 cycle 8 40
th
 cycle 
The results for CXCL2 gene are shown in Figure 3.2. The optimum cycle number 
was observed as 35 for CXCL2. Thus the following PCR program was used in the rt-
PCR experiments: 55
 °
C (30 min) for cDNA synthesis, 94
 °
C (2 min) for initial 
denaturation and then 35 cycles at 94
 °
C (15 sec) / 58
 °
C (30 sec) / 68
 °
C (30 sec) and 
a final extension at 68
 °
C (5 min). 
 
Figure 3.2: Optimization of PCR cycle number for CXCL2 
Table 3.2: Explanation of bands in Figure 3.2 
Lane Explanation Lane Explanation 
1 Marker 5 32
nd
 cycle 
2 23
rd
 cycle 6 35
th
 cycle 
3 26
th
 cycle 7 38
th
 cycle 
4 29
th
 cycle 8 40
th
 cycle 
  9 Control 
3.1.2 PCR optimization 
DNA contamination test experiment was conducted to check whether the  
nonspecific band was resulting from DNA contamination during RNA isolation. For 
this purpose, the same PCR reaction was performed using Taq polymerase instead of 
RT/Platinum Taq Mix. The results are shown in Figure 3.3. The results revealed that 
the mRNAs did not contain any DNA contamination. 
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                             a                                                                      b 
Figure 3.3: DNA contamination experiment gel images a) sample 3, 18, 26 and 
control  b) sample 1, 5, 14, 16, 28, 29, Sham-A and Sham-B. 
Table 3.3: Explanation of  bands in Figure 3.3 
Lane  Explanation Lane  Explanation 
1 Sample 3 9 Sample 16 
2 Sample 18 10 Sample 28 
3 Sample 26 11 Sample 29 
4 Control 12 Sham A 
5 Marker 13 β-actin 
6 Sample 1 14 Sham B 
7 Sample 5 15 Control 
8 Sample 14   
Primer dimers experiment was also conducted to test if the bands were primer 
dimers. For this purpose, PCR reaction mixtures containing only one primer of each 
primer pairs and both primers of the primer pairs for CXCL2 by using 0.4 µl Taq 
DNA polymerase (2 units) were prepared. This procedure was performed for all of 
the samples. 
The results are shown in Figure 3.4 which indicate that the bands were primer 
dimers. Only the primer pairs showed the same band, but the single primers  did not 
show any band because of the fact that EtBr only binds to double stranded DNA. 
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Figure 3.4: Gel images of Primer dimers control using CXCL2 and DUSP1 primers 
Table 3.4: Explanation of  bands in Figure 3.4 
Lane Explanation Lane Explanation 
1 DUSP1 R 5 CXCL2 R 
2 DUSP1 F 6 CXCL2 F 
3 DUSP1 F+R 7 CXCL2 F+R 
4 DUSP1 K 8 CXCL2 K 
  9 Marker 
Annealing temperature and time were optimized for DUSP1 by varying  these 
parameters between 53
 °
C (90 sec); 56 
°
C (30 sec) and 60
 °
C (30 sec). The band of 53
 
°
C (90 sec) conditions was brighter than the other conditions for annealing time and 
temperature (Figure 3.5 and 3.6). 
 
Figure 3.5: Gel images of CXCL2 and DUSP1 gene optimization using 56 
°
C (30 
sec) and 60
 °
C (30 sec) 
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Table 3.5: Explanation of  bands in Figure 3.5 
Lane Explanation Lane Explanation Lane Explanation 
1 Marker 11 29. cycle, 56 
°
C, 
DUSP1   
21 38. cycle, 60 
°
C, 
CXCL2 
2 23. cycle, 56
 °
C, 
CXCL2 
12 32. cycle, 56 
°
C, 
DUSP1   
22 40. cycle, 60 
°
C, 
CXCL2 
3 26. cycle,56
°
C, 
CXCL2 
13 35. cycle, 56 
0
C, 
DUSP1   
23 23.cycle,60
°
C, 
DUSP1   
4 29. cycle,56 
°
C, 
CXCL2 
14 38. cycle, 56 
°
C, 
DUSP1   
24 26. cycle, 60 
°
C, 
DUSP1   
5 32. cycle, 56
°
C, 
CXCL2 
15 40. cycle, 56 
°
C, 
DUSP1   
25 29. cycle, 60 
°
C, 
DUSP1   
6 35. cycle, 56
°
C, 
CXCL2 
16 23. cycle, 60
°
C, 
CXCL2 
26 32. cycle, 60 
°
C, 
DUSP1   
7 38.cycle, 56
°
C, 
CXCL2 
17 26. cycle, 60
°
C, 
CXCL2 
27 35. cycle, 60 
°
C, 
DUSP1   
8 40. cycle, 56
°
C, 
CXCL2 
18 29. cycle, 60
°
C,  
CXCL2 
28 38. cycle, 60 
°
C, 
DUSP1   
9 23. cycle, 56
°
C, 
DUSP1   
19 32. cycle, 60 
°
C, 
CXCL2 
29 40. cycle, 60 
°
C, 
DUSP1   
10 26.  cycle, 56 
°
C, 
DUSP1 
20 35. cycle, 60 
°
C, 
CXCL2 
30 Control 
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Figure 3.6: Gel image of DUSP1 gene optimization using 53
 °
C (90 sec) 
Table 3.6: Explanation of  bands in Figure 3.6 
Lane Explanation Lane Explanation 
31 23.cycle, 53
°
C, DUSP1 35 35. cycle, 53 
°
C, DUSP1 
32 26. cycle,53
°
C, DUSP1 36 38. cycle, 53 
°
C, DUSP1 
33 29. cycle, 53
°
C, DUSP1 37 40. cycle, 53 
°
C, DUSP1 
34 32. cycle, 53 
°
C, DUSP1   
CXCL2 gene optimization using the first primer set was continued with 56 
°
C (30 
sec) and 60 
°
C (30 sec). When the nonspecific band was observed again, gradient 
PCR was decided to be performed 55 
°
C- 65 
°
C and the extension time was reduced 
from 50 sec to 30 sec. At all temperatures, however, the band between 200 kb and 
300 kb was clearly visible (Figure 3.7). 
 
Figure 3.7: Gel images of Gradient PCR with first primer set (CXCL2 gene) 
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Table 3.7: Explanation of  bands in Figure 3.7 
Lane Explanation Lane Explanation 
1 Marker 8 61 °C 
2 55 °C 9 62.1 °C 
3 56 °C 10 63.1 °C 
4 56.9 °C 11 64 °C 
5 57.9 °C 12 65 °C 
6 58.8 °C 13 60.4°C(Control) 
7 60.4 °C   
The brighter band of CXCL2 gene during Gradient PCR was 58 
°
C (Figure 3.7). The 
annealing time at this temperature was reduced from 30 sec to 20 sec. 
The nonspecific band at 62 
°
C was the least visible one when the nonspecific band 
was compared with those at the other temperatures (Figure 3.7). Afterwards the 
optimizations were kept going with this temperature by reducing the annealing time 
to 20 sec and 10 sec (Figure 3.8). The extension time was then reduced from 50 sec 
to 30 sec and even to 11 sec and 10 sec (Figure 3.9). 
  
Figure 3.8: Gel images of CXCL2 gene using a) 58
°
C (20 sec), 62
°
C (20 sec) 
                    b)62
°
C (10 sec) with first primer set 
Table 3.8: Explanation of  bands in Figure 3.8 
Lane Explanation Lane Explanation 
1 Marker 5 Control, 62
°
C (20 sec) 
2 Sample 3, 58
°
C (20 
sec) 
6 Marker 
3 Control, 58
°
C (20 sec) 7 Sample 3, 62
°
C (10 
sec) 
4 Sample 3, 62
°
C (20 
sec) 
8 Control, 62
°
C (10 sec) 
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Further optimization was performed by adding MgSO4 to the concentration mixtures 
to a final concentration of 1.8 mM and 2mM MgSO4 to reduce nonspecific band 
(Figure 3.9). 
 
Figure 3.9: Gel images of CXCL2 gene using first and second primer set and 
different MgSO4 concentration 
Table 3.9: Explanation of  bands in Figure 3.9 
Lane Explanation Lane Explanation 
1 Marker 7 
Control (annealing 62
°
C,30 
sec;extension 68
°
C 50sec) 
2 
Sample3 (annealing 62
°
C, 30 
sec;extension 68
°
C 11sec) 
8 
Sample3 (annealing 64
°
C,30 
sec;extension 68
°
C 50sec) 
3 
Control (annealing 62
°
C,30 
sec;extension 68
°
C 11sec) 
9 
Control (annealing 64
°
C,30 
sec;extension 68
°
C 50sec) 
4 
Sample3 (annealing 62
°
C,30 
sec;extension 68
°
C 50sec) 
10 
Sample3 (annealing 64
°
C,30 
sec;extension 68
°
C 50sec) 
5 
Control (annealing 62
°
C,30 
sec;extension 68
°
C 50sec) 
11 
Control (annealing 64
°
C,30 
sec;extension 68
°
C 50sec) 
6 
Sample3 (annealing 62
°
C,30 
sec;extension 68
°
C 50sec) 
  
However, none of these optimization procedures using the first primer set of CXCL2 
were successful and the nonspecific band could not be eliminated. 
The optimizations that were done using the second primer set began with annealing 
temperature and time as 53
°
C (90 sec) and continued with 56
°
C (30 sec). Gradient 
PCR was then done as with the first primer set by using the second primer set (Figure 
3.10). The nonspecific band at 64
°
C was the least visible nonspecific band, among all 
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other samples tested at different temperatures. Additionally, 1.8 mM and 2mM 
MgSO4 was also added to the PCR mixture for further optimizitaion. 
 
Figure 3.10: Gel images of Gradient PCR with second primer set (CXCL2 gene) 
Table 3.10: Explanation of  bands in Figure 3.10 
Lane Explanation Lane Explanation 
1 Marker 7 60 °C 
2 55 °C 8 61 °C 
3 56 °C 9 61.9 °C 
4 57.1 °C 10 62.9 °C 
5 58.1 °C 11 63.9 °C 
6 59.1 °C 12 65 °C 
However, none of these experiments could eliminate the nonspecific band. 
Touchdown PCR was carried out using different temperatures and cycle numbers. 
The optimum Touchdown PCR experiment was  the one applied according to the 
following program: 55 
°
C (30 min) for cDNA synthesis, 94 
°
C (2 min) for initial 
denaturation and then 40 cycles at 94
0
 C (15 sec), the annealing temperature  by 1
°
C 
every  cycle from  70 
°
C to a touchdown of 64 
°
C (30 sec) at which 35 cycles were 
carried out; 68
°
C (30 sec) and a final extension at 68 
°
C (5 min) (Figure 3.11). The 
nonspecific band was visible at the other touchdown PCR experiments. 
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Figure 3.11: Gel images of optimum Touchdown PCR  
Table 3.11: Explanation of  bands in Figure 3.11 
Lane Explanation 
1 Marker 
2 Sample 3 
 
The nonspecific band disappeared only in sample 3 ( HP_I45_R15_A) and the band 
of CXCL2 gene was observed only at the 40 cycle. Before 40
th
 cycle, no 
amplification product was observed.  When the experiment was done using sample 
number 18, there was no amplification product even at the 40
th
 cycle (Figure 3.12). 
 
Figure 3.12: Gel images of optimum touchdown PCR at the 40
th
 cycle using  
a) sample 3 b) sample 18 
Table 3.12: Explanation of  bands in Figure 3.12 
Lane Explanation Lane Explanation 
1 Marker 6 Sample 3, 35.cycle 
2 Sample 3, 23. cycle  7 Sample 3, 38.cycle 
3 Sample 3, 26. cycle 8 Sample 3, 40.cycle 
4 Sample 3, 29. cycle 9 Marker 
5 Sample 3, 32. cycle 10 Sample 18, 40. cycle 
Finally, as a result of all optimizations, annealing temperature and time were chosen 
as 58 
°
C and 30 sec; and extension temperature and time were chosen as 68
°
C and 30 
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sec, respectively. While the volume of the nonspecific band  was decreasing ,the 
specific band volume was also decreasing. Thus, 58
°
C was chosen as the optimal 
annealing temperature, in order not to lose the specific band (Figure 3.7). 
3.1.3 Multiplex rt-PCR  
All samples were run in duplicate. 
 
Figure 3.13: DUSP1 Multiplex RT-PCR results 
Table 3.13: Explanation of  bands in Figure 3.13 
Lane Explanation Lane Explanation Lane Explanation 
1 Marker 
(#SM0323, 
Fermentas) 
12-13 Sample-18 (I45-R60-
B) 
22-23 Sample-31 (Sham-A) 
with only beta-actin 
primers 
2-3 Sample-1 (HP-
I45-R0-A) 
14-15 Sample-26 (IP-I45-
R0-B) 
24-25 Sample-32 (Sham-B) 
with DUSP1 and beta-
actin primers 
4-5 Sample-3 (HP-
I45-R15-A) 
16-17 Sample-28 (IP-I45-
R15-B) 
26-27 Sample-32 (Sham-B) 
with only beta-actin 
primers 
6-7 Sample-5 (HP-
I45-R60-A) 
18-19 Sample-29 (IP-I45-
R60-A) 
28-29 Controls with only 
beta-actin primers 
(sample 26) 
8-9 Sample-14 (I45-
R0-B) 
20-21 Sample-31 (Sham-A) 
with DUSP1 and 
beta-actin primers 
30 Control with DUSP1 
and beta-actin primers 
and with no template 
10-11 Sample-16 (I45-
R15-B) 
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Figure 3.14: CXCL2 Multiplex RT-PCR results 
Table 3.14: Explanation of  bands in Figure 3.14 
Lane Explanation Lane Explanation Lane Explanation 
1 Marker 
(#SM0323, 
Fermentas) 
12-13 Sample-18 (I45-R60-
B) 
22-23 Sample-31 (Sham-A) 
with only beta-actin 
primers 
2-3 Sample-1 (HP-
I45-R0-A) 
14-15 Sample-26 (IP-I45-
R0-B) 
24-25 Sample-32 (Sham-B) 
with CXCL2 and beta-
actin primers 
4-5 Sample-3 (HP-
I45-R15-A) 
16-17 Sample-28 (IP-I45-
R15-B) 
26-27 Sample-32 (Sham-B) 
with only beta-actin 
primers 
6-7 Sample-5 (HP-
I45-R60-A) 
18-19 Sample-29 (IP-I45-
R60-A) 
28-29 Controls with only 
beta-actin primers 
(sample 26) 
8-9 Sample-14 
(I45-R0-B) 
20-21 Sample-31 (Sham-A) 
with CXCL2 and 
beta-actin primers 
30 Control with CXCL2 
and beta-actin primers 
and with no template 
10-11 Sample-16 
(I45-R15-B) 
    
 
3.2 Real-time PCR Experiments 
DUSP1 and CXCL2 gene expression analysis was also performed using real-time 
PCR, a more sensitive method than rt-PCR. 
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The total RNA population was reverse transcribed with random hexamers so that 
different PCR analyses could be performed on the same cDNA sample. Reaction mix 
are given as given in the Table 2.13 and 2.14. 
The error rates of the Real-Time PCR reactions of DUSP1 and β-actin were about 
0.3% and the efficiencies of these reactions were  approximately 2 (Table 3.15). 
Table 3.15: Error rates and efficiencies of  DUSP1 and β-actin real-time PCRs. 
 DUSP1 β-actin 
Error Rate 0.0317 0.0252 
Efficiency 2.062 2 
The error rates and efficiencies of DUSP1 and beta actin were in an acceptable range 
(Table 3.1). However, the efficiency of CXCL2 gene was not between 1.8 and 2.2 
and error rate was higher than 2%.  Firstly, sample number 3 was used to set the 
standard curve optimization because of its high volume. The Ct of undiluted sample 
was over 30 cycles and Ct‘s of  the dilutions of 1/10 and 1/100  near 40 cycles, and 
of 1/1000 was over 40 cycles. The higher Ct values reduce the efficiency. When 
unsatisfactory efficiency values were obtained, the sample changed with Sham B 
(control) because of higher concentration of Sham B. However, the results did not 
change. 
The standards were prepared in undiluted, 1/2 diluted, 1/4 diluted and 1/8 diluted 
forms to prevent the Ct values from reaching 40 cycles. However, neither the 
efficiency nor the error values were still in an acceptable range, but β-actin efficiency 
and error values were in an acceptable range during CXCL2& β-actin multiplex 
assay(Table 3.16). 
Primer and probe volumes of CXCL2 gene were increased from 0.4 µl to 0.6 µl 
using sample 16 (I45_R15_B) to test if the high Ct value could be reduced. However, 
Ct value of sample 16 remained unchanged. 
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Table  3.16:  Error rates and efficiencies of CXCL2 and β-actin Real-Time PCRs. 
 CXCL2  β-actin 
Error Rate >>>0.2  0.00776 
Efficiency 2.347 2.105 
3.3 Relative Quantification of RT-PCR Results 
3.3.1 DUSP1 gene expression levels as quantified by RT-PCR 
When the mRNA levels were normalized and calibrated according to the endogenous 
control and the standard dilutions, relative expression levels were obtained. Shams 
were considered to be 1 as relative expression units. 
When the calibrator was chosen as Sham A for DUSP1 gene, the lowest gene 
expression level was observed within the ischemia reperfusion injury group (N=1; 
0.075 relative expression) and the highest gene expression was observed within 
ischemic preconditioning group (N=1; 1.028 relative expression) (Figure 3.15 ) . 
In the heat preconditioning group and ischemia reperfusion injury group, as it was 
observed that the reperfusion time increased, DUSP1 gene expression also increased.  
In the HP-I45-R0-A sample (N=1; 0.180 relative expression), DUSP1 gene was 
downregulated as compared to Sham A. As the reperfusion time increased, DUSP1 
gene was upregulated in both samples HP-I45-R15-A (N=1; 1.023 relative 
expression) and HP-I45-R60-A (N=1; 1.03 relative expression)  but there was no  
significant difference when these two samples were compared with Sham A. 
Upregulation was observed in  I45-R15-B (N=1; 0.99 relative expression) and  I45-
R60-B (N=1; 1.019 relative expression) compared to I45-R0-B (N=1; 0.075 relative 
expression) (Figure 3.15). 
In the ischemic preconditioning group, at 15 min reperfusion, the expression of 
DUSP1 gene slightly decreased. It was upregulated in 60 min reperfusion samples. 
However, downregulation and upregulation were not significant when the samples 
were compared with Sham A (Figure 3.15). 
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Figure 3.15:  Relative quantification of DUSP1 gene expression normalized to Sham 
A according to rt-PCR 
There was no significant difference in the results of  DUSP1 gene expression in each 
sample whether the calibrator was  Sham A or Sham B (Figure 3.15 and 3.16). 
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Figure 3.16: Relative quantification of DUSP1 gene expression normalized to sham 
B according to RT-PCR results. 
3.3.2 CXCL2 gene expression levels  as quantified by rt-PCR 
CXCL2 gene was not expressed in samples HP-I45-R0-A, HP-I45-R15-A, I45-R0-B 
and I45-R15-B. However, it was upregulated in samples HP-I45-R60-A (N=1; 1.09 
relative expression)  and I45-R60-B (N=1;  1.12 relative expression) (Figure 3.17). 
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Figure 3.17: Relative quantification of CXCL2 gene expression normalized to sham 
A according to RT-PCR results 
The relative expression levels of those two samples were higher when the results 
were normalized to Sham B (Figure 3.18). In ischemic preconditioning group, all 
three samples were upregulated in comparison to both Sham A and Sham B. Samples 
IP-I45-R0-B and IP-I45-R15-B had the same fold increase values. 
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Figure 3.18: Relative quantification of CXCL2 gene expression normalized to sham 
B according to RT-PCR results 
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3.4 Relative Quantification of Real-Time PCR Results 
3.4.1 DUSP1 gene expression levels as quantified by real-time PCR 
When the calibrator was chosen as Sham A, DUSP1 was observed to be 
downregulated in Sample HP-I45-R0-A. Increase in gene expression was observed 
when the reperfusion time increased to 15 min for the sample HP-I45-R15-A. 
However, the DUSP1 expression of both of these samples were the lower compared 
to that of Sham A (Figure 3.19). 
A reperfusion time of 60 min in the sample HP-I45-R60-A resulted in more than two 
fold increased expression levels compared to Sham A. 
Sample I45-R0-B had 0.43 Relative Expression Units but as the reperfusion time 
increased to 15 min (Sample I45-R15-B) Relative Expression Units decreased to 
0.36. The highest relative expression in the ischemia-reperfusion group was observed 
with the sample I45-R60-B corresponding to 60 min reperfusion time (Figure 3.19). 
All samples in the ischemic preconditioning group had higher relative expression 
levels for DUSP1, compared to Sham A. Among all 9 samples from 3 different 
conditions, sample IP-I45-R60-A had the highest relative expression (N=1; 2.84 
relative expression) (Figure 3.19). 
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Figure 3.19: Relative quantification of DUSP1 gene expression normalized to sham 
A according to Real-time PCR results 
DUSP1 gene expression levels were higher when normalized to Sham B, compared 
to normalisation to Sham A for all samples (Figure 3.19 and 3.20). This difference 
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was particularly significant for samples  IP-I45-R60-A and I45-R60-B. More than 3 
fold increase was observed in gene expression of the sample IP-I45-R60-A when the 
calibrator was Sham B. The relative expression unit was 2.1 for sample I45-R60-B, 
but only 1.81 for the same sample, when Sham A was the calibrator. 
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Figure 3.20: Relative quantification of DUSP1 gene expression normalized to sham 
B according to Real-time PCR results 
3.4.2 CXCL2 gene expression levels as quantified by real-time PCR 
When the calibrator was chosen as Sham A, CXCL2 gene expression level for  
samples HP-I45-R0-A and HP-I45-R15-A were more than one fold. CXCL2 gene 
was not expressed in sample I45-R0-B. The highest relative expression was observed 
at sample I45-R60-B. The relative expression levels of all samples of ischemic 
preconditioning group was more than 5-fold. All samples that were reperfused for 60 
min had the highest relative expression in their particular group (Figure 3.21). 
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Figure 3.21: Relative quantification of CXCL2 gene expression normalized to sham 
A according to real-time PCR results 
For CXCL2 gene, the relative expression level that were calculated according to 
Sham A were two-fold than the relative expression levels calculated according to 
Sham B (Figure 3.22). 
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Figure 3.22: Relative quantification of CXCL2 gene expression normalized to sham 
B according to real-time PCR results 
 
 
 
 
  
60 
3.5 Comparison of RT-PCR&Real-time PCR results with previously obtained 
microarray results and Statistical Analysis 
Table  3.17: Comparison of  DUSP1 gene RT-PCR&Real-time PCR results with 
previously obtained microarray results  
 DUSP1/shamA ratio DUSP1/shamB ratio 
SAMPLES 
RT-
PCR 
 
 
Real-time 
pcr 
 
 
M.array 
 
RT-
PCR 
 
Real-time 
pcr 
 
M.array 
 
HP-I45-R0-A (1) 
 
0.180 
 
0.34 
 
-1.27 
 
0.17 
 
0.4 
 
-1.51 
 
HP-I45-R15-A (3) 
 
1.023 
 
0.46 
 
-1.15 
 
0.99 
 
0.53 
 
-1.2 
 
HP-I45-R60-A (5) 
 
1.03 
 
2.06 
 
1.6 
 
1.002 
 
2.41 
 
1.47 
 
I45-R0-B (14) 
 
0.075 
 
0.43 
 
-0.97 
 
0.07 
 
0.51 
 
-1.24 
 
I45-R15-B (16) 
 
0.99 
 
0.36 
 
-0.79 
 
0.96 
 
0.42 
 
-1.01 
 
I45-R60-B (18) 
 
1.019 
 
1.81 
 
1.14 
 
0.99 
 
2.1 
 
1.18 
 
IP-I45-R0-B (26) 
 
1.016 
 
1.36 
 
1.06 
 
0.98 
 
1.59 
 
1.19 
 
IP-I45-R15-B (28) 
 
1.006 
 
1.32 
 
1.2 
 
0.98 
 
1.54 
 
1.1 
 
IP-I45-R60-A (29) 
 
1.028 
 
2.84 
 
1.05 
 
1.001 
 
3.31 
 
1 
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Table 3.18: Comparison of  CXCL2 gene RT-PCR&Real-time PCR results with  
previously obtained microarray results  
 CXCL2/shamA ratio CXCL2/shamB ratio 
SAMPLES 
RT-
PCR 
 
 
Real-time 
pcr 
 
 
M.array 
 
RT-
PCR 
 
Real-time 
pcr 
 
M.array 
 
HP-I45-R0-A (1) 
 
0 
 
1.095 
 
-0.18 
 
0 
 
0.56 
 
0.14 
 
HP-I45-R15-A (3) 
 
0 
 
1.73 
 
-0.31 
 
0 
 
0.89 
 
0.24 
 
HP-I45-R60-A (5) 
 
1.09 
 
9.4 
 
1.66 
 
1.36 
 
4.84 
 
1.52 
 
I45-R0-B (14) 
 
0 
 
0 
 
0.03 
 
0 
 
0 
 
-0.04 
 
I45-R15-B (16) 
 
0 
 
2.18 
-0.35 
 
0 
 
1.12 
 
-0.16 
 
I45-R60-B (18) 
 
1.12 
 
10.4 
 
1.92 
 
1.4 
 
5.35 
 
1.94 
 
IP-I45-R0-B (26) 
 
1.14 
 
5.15 
 
1.49 
 
1.42 
 
2.66 
 
1.53 
 
IP-I45-R15-B (28) 
 
1.14 
 
6 
 
0.91 
 
1.42 
 
3.09 
 
1.01 
 
IP-I45-R60-A (29) 
 
1.036 
 
8.8 
 
1.44 
 
1.29 
 
4.5 
 
1.52 
 
 
Friedman test was used to test the relationship between RT-PCR, real-time PCR and 
microarray results. The results of  DUSP1 and CXCL2 gene expression were tested 
when normalized to Sham A and Sham B. For a good correlation, W value should be 
between 0.70 and 1, and the P value should be more than 0.01, in order not to have 
any significant differences between RT-PCR, real-time PCR and microarray results. 
Table 3.19: p values and Kendall coefficient of concordance for RT-PCR, real-time 
PCR and microarray of DUSP1 and CXCL2 gene expression 
 DUSP1&ShamA Dusp1&ShamB CXCL2&ShamA CXCL2&ShamB 
 P value  W P value W P Value W P Value W 
HP 0.264 0.444 0.264 0.444 0.097 0.778 0.050 1 
IRI 0.050 1 0.264 0.444 0.441 0.273 0.097 0.778 
IP 0.264 0.444 0.097 0.778 0.097 0.778 0.148 0.636 
p values showed that the results of the three experimental methods were not 
significantly different from each other, thus indicating a good correlation. Kendall‘s 
coefficent of concordance values of the results were generally in an acceptable range 
(Table 3.19). 
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4. DISCUSSION & CONCLUSIONS 
Acute renal failure (ARF) is an inflammatory consequence of a sudden and 
temporary interruption of blood flow in the kidneys and it remains as a common 
issue in the clinical practice which lack satisfactory therapeutic options (de Paiva et 
al., 2008).  
Important cause of morbidity and mortality in hospitalized intensive care unit 
patients is acute renal failure from ischemic damage (Hamar et al., 2004).  
ARF pathogenesis leads to the sudden interruption of blood flow to the kidneys 
starting inflammation and innate immune responses such as production of reactive 
oxygen species, complement and neutrophils activation, up-regulation of adhesion 
molecules and tubular cell death (de Paiva et al., 2008). 
Upregulation of adhesion molecules, chemokines and HSPs in experimental brain 
dead donor kidneys are known and upregulation of these genes are also confirmed in 
cardiac death donor kidneys (Kusaka et al., 2006). 
The involvement of renal IRI in upregulation of proinflammatory cytokines and the 
actual role of cytokines has become apparent (Bertocchi et al., 2008). 
Real time PCR is the most sensitive method for the detection and quantification of 
gene expression levels, in particular for low abundant transcripts in tissues with low 
RNA concentrations, from limited tissue sample and for the elucidation of small 
changes in mRNA expression levels (Pfaffl, 2005). Thus, results from real time PCR 
and RT-PCR experiments were compared with each other, and also to previous 
microarray results with the same samples. 
The results of RT-PCR and Real-time PCR experiments show that CXCL2 gene was 
not expressed when the sample is only subjected to ischemia (I45-R0-B). The results 
obtained from gene expression analysis using quantitative real-time PCR, indicated 
that expression levels increased with reperfusion time. Apparently, when the blood 
flow began, CXCL2 gene was expressed because of the ROS production upon blood 
flow and the beginning of inflammation. In the heat preconditioning (HP) and 
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ischemia reperfusion (IR) groups, 60 min reperfusion time samples had the highest 
CXCL2 gene expression levels, according to both RT-PCR and real-time PCR 
results. The results according to Sham A and Sham B controls differed from each 
other for CXCL2 gene in their absolute values, but not the general tendency in gene 
expression levels. The Real-time PCR and RT-PCR results were in agreement with 
microarray results for CXCL2. CXCL2 gene was induced in all samples except     
HP-I45-R0-A, HP-I45-R15-A. There seems to be a downregulation for CXCL2 gene 
expression normalized to Sham B in HP-I45-R0-A and HP-I45-R15-A samples 
according to Real-time PCR results, but no expression was observed for same 
samples in rt-PCR analysis. This may result from the differences in sensitivities of rt-
PCR and real-time PCR, the latter being more sensitive (Figures 3.17, 3.18, 3.21 and 
3.22). IPC generally increase CXCL2 gene expression. The increase in reperfusion 
time in IPC group did not cause a significant increase in CXCL2 gene expression. In 
HP and IRI, however, CXCL2 gene expression increased significantly as a function 
of reperfusion time (Figures 3.21 and 3.22).  
Salt, alcohol, phenol and other inhibitors carried over from the RNA isolation 
process can affect the apparent RT efficieny (Pfaffl, 2005). RNAs had previously 
been isolated using peqGOLD TriFast
TM
 (Tektaş, Ph.D Thesis), and this method 
involved the use of phenol. It is likely that reason for the low efficiency of CXCL2 
results could be due to the use of  phenol in RNA isolation. 
Priming method that was used to initiate cDNA synthesis  can be either gene specific 
or non-specific (Pfaffl, 2005). Nonspecific cDNA synthesis was chosen because the 
experiments for two genes were applied for the same samples. In nonspecific 
method, random hexamer was chosen as Pfaffl (2005) observed that it was the most 
efficient primer in nonspecific primers. 
Two general methods for the quantitative detection of the amplicon have become 
established: gene specific fluorescent probes or specific double strand DNA binding 
agents as SYBR green (Pfaffl, 2005). In RT-PCR experiments, a  nonspecific band 
was observed for CXCL2 samples, thus it was decided to use Taqman probe for real-
time PCR experiments to obtain more specific results. 
Regarding quantification, the first decision was the use of Roche LightCycler 
Relative quantification program. However, CXCL2 efficiency values was not within 
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the acceptable range. Thus, the method for relative quantification was changed to 
ΔΔCt method. 
The dynamic range of the performed calibration  curve can be up to nine orders of 
magnitude from <10
1 
to  >10
10 
 start molecules, depending on the applied standard 
material (Pfaffl, 2005). As the samples that were used in this study were RNA 
samples of limited amount, it was not possible to use 10
2
, 10
3 
 start molecules. 
Instead, undiluted, 10
-1
, 10
-2
, and 10
-3 
start molecules were used. The use of more 
undiluted samples could bring the efficiency values between 1.8 and 2.2.  
In all experiments in this study, the genes of interest and the housekeeping gene          
(beta-actin) serving as an internal control were co-amplified in the same reaction 
tube. Thus, they were amplified under the same conditions. Normalization with 
genes that were in the same tube should have minimized technical problems.  
During PCR, formation of primer dimers competes with formation of specific PCR 
product, leading to reduced amplification efficiency and a less successful specific 
Real-Time PCR product (Pfaffl, 2005). Although probe based real time PCR was 
used, primer dimer formation was observed for CXCL2 gene. 
Different tissues exhibit different PCR efficiencies, caused by RT inhibitors, PCR 
inhibitors, and by variations in the total RNA fraction pattern extracted (Pfaffl, 
2005). The efficiency of CXCL2 gene may be affected by these inhibitors. 
CXCL2 efficiency was reduced by late amplification cycles. All samples for CXCL2 
gene have high threshold cycle values above the acceptable range of quantification 
[Ct > 30 cycles]. This high threshold cycle value reduces the efficiency of CXCL2 
gene. Behrends et al. (2007) observed the same result for the same gene. CXCL2 
gene was also expressed in the control samples  Sham A and Sham B. 
In response to extracellular stimulation, MKP-1 mRNA levels are usually increased 
by 10–100 fold within 15-60 min (Wang and Liu, 2007). In all groups, DUSP1 gene 
expression was highest when reperfusion time was 60 min. The Real-time PCR and 
RT-PCR results were generally in agreement with microarray results for DUSP1. 
According to real-time PCR results, downregulation of DUSP1 was observed in   
HP-I45-R0-A, HP-I45-R15-A, I45-R0-B, I45-R15-B samples (Figures 3.19 and 
3.20). DUSP1 gene was induced in all of the samples of ischemic preconditioning 
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group. These results imply that DUSP1 gene is downregulated in response to 
hypoxia.
  
Microarray, RT-PCR and Real-time PCR results can be discordant with each other. 
The discordance of these results may be explained by the decreased sensitivity of the 
microarray per se or by the relatively low expression levels of these genes (Bruder et 
al., 2007). 
Real-time PCR also offers a much wider dynamic range of up to 10
7
-fold (compared 
to 1000-fold in conventional RT-PCR) in comparison to conventional RT-PCR 
(Dorak, 2006). The ranges of relative quantification values were indeed higher in our 
real-time PCR results, compared with those of rt-PCR and microarray (Tables 3.17 
and 3.18). 
The lower values of Kendall‘s coefficient of concordance could possibly be 
explained by the zero expression levels and minus values of some microarray data. 
To summarize, the early preconditioning effects on DUSP1 and CXCL2 gene 
expression levels were investigated in detail in this study by successfully applying rt-
PCR and real-time PCR techniques and comparing them to previously obtained 
microarray results. Generally, it was observed that, as the reperfusion time increased, 
the gene expression levels also increased, up to 60 min reperfusion time. Thus, it 
remains to be investigated what changes would occur in gene expression for 
reperfusion times longer than 60 min. Such new experiments would be useful to 
investigate late preconditioning effects. 
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